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SUMMARY
Several facts suggest that histamine may influence 
the function of cerebral blood vessels. 1)
Histamine has important vascular effects in non- 
neural organs; 2) Cerebral microvessels and 
arteries contain receptors for histamine; 3)
Enzyme systems in brain capillaries, particularly 
adenylate cyclase, are sensitive to histamine; 4) 
Cerebral perivascular mast cells store histamine;
5) A non-mast cell pool of histamine is located 
within cerebral vascular smooth muscle; 6) Hista- 
minergic nerves are present in brain, and may 
innervate blood vessels; and 7) Histamine may 
modulate noradrenergic nerve activity'in cerebral 
vessels.
In the studies that form the basis for this thesis,
I have examined several aspects of brain vascular 
responses to histamine. These include an examinat­
ion of blood-brain barrier permeability during carotid 
arterial infusion of histamine, cerebral blood flow 
responses to arterial infusion of histamine and its 
agonists, and responses of pial arterioles and veins 
to 1) perivascular injection of histamine agents, and
2) the interaction of noradrenergic and histaminergic 
stimuli.
In the studies examining cerebrovascular permeability 
(blood-brain barrier), histamine was infused into 
the internal carotid artery of anaesthetised rats, 
and quantitative measurements were made of vascular 
permeability to sucrose and a neutral amino acid, 
alpha-aminoisobutyric acid. Histamine increased 
permeability up to 237% in several brain regions (e.g., 
diencephalon, caudate nucleus, hippocampus, cerebral 
cortex) and in different areas of cerebral cortex 
(e.g., visual, parietal, frontal, olfactory).
Additional studies indicated that the permeability 
increase was reversible: it had persisted for at
least 30 minutes, but permeability had returned to 
normal within two hours. Pretreatment by intra­
venous injection with the histamine H 2 receptor 
antagonist, metiamide, blocked the increase in 
permeability, while antagonism at receptors 
with mepyramine was ineffective. Studies determin­
ing regional brain water content indicated that 
oedema in cortical grey matter occurred during 
histamine infusion.
Measurements of cerebral blood flow in anaesthetised 
rats.were made by the intracarotid ^Xenon clearance 
technique and also by tissue sampling to determine 
the brain distribution of tracer after systemic 
administration of labeled lodoantipyrine. Blood 
flow was measured before and after disruption of the 
blood-brain barrier by carotid injection of hypertonic 
urea. When the blood-brain barrier was intact, 
histamine had no effect on cerebral blood flow.
After barrier opening, histamine increased blood flow 
in a concentration-dependent manner (26% to 50%).
The participation of both histamine and H 2 receptors 
in mediating increases in blood flow was demonstrated 
by studies with the respective receptor antagonists 
during histamine infusion, and by carotid infusion of 
specific receptor agonists after blood-brain barrier 
opening. Dilatation of cerebral Vessels during 
histamine infusion was not a secondary result to 
increased brain metabolism.: histamine infusion after 
blood-brain barrier disruption did not produce detect­
able increases in cerebral glucose uptake. These 
results suggest that histamine acted on receptors with­
in vascular smooth muscle to produce increases in 
blood flow.
Pial arteriolar and venous responses to histamine and 
its pharmacological agonists were determined in 
anaesthetised cats by measuring vessel calibre before 
and after perivascular injection. Both and
receptors could mediate dilatation in arterioles, 
but with different maximum effects. The rank order 
of potency in producing dilatation by the receptor 
stimulants, and maximum responses elicited, were 
(+43%)^  histamine (+28%)^ (+17%). By contrast,
pial veins did not respond significantly to the 
histamine agents.
Whether histamine could influence vasoconstrictor 
effects of sympathetic nerve stimulation and 
exogenous noradrenaline was also studied in cat pial 
vessels. In arterioles, stimulation of receptors 
inhibited the constriction by nerve stimulation, but 
not that resulting from exogenous noradrenaline; 
receptors interfered with constrictor effects 
produced by both kinds of noradrenergic stimuli. In 
veins, both histamine receptor types inhibited the 
effects of nerve stimulation, but did not influence 
responses to noradrenaline. These experiments suggest 
that both and receptors inhibit noradrenergic 
activity by acting at prejunctional sites in cerebral 
arterioles and veins. In arterioles, noradrenergic 
postjunctional mechanisms are affected only by 
receptors, while in veins, histamine receptors appear 
to have no influence at this neuroeffector site.
From concepts developed in the separate parts of this 
thesis, I formulated a unifying hypothesis that 
proposes a spatial and differential orientation of 
receptor sites for histamine in cerebral vessels.
The following is a possible profile of histamine 
receptor distribution within the cerebral vessel 
wall; 1) endothelia: predominantly H 2 receptors; 2) 
inner layers of smooth muscle; both and receptors; 
and 3) outer layers of smooth muscle: predominantly
receptors.
PREFACE AND DECLARATION
The biogenic amine, histamine (p-imidazolylethylamine), 
has been the subject of considerable experimental 
interest since the pioneering experiments of Sir 
Henry Dale seventy years ago. Among its diverse 
physiological activities, the influence of histamine 
on the function of blood vessels is known, for 
peripheral organs, to be of cardinal importance to 
the regulation of local blood flow and exchange of 
materials in the microcirculation. In the brain, 
histamine has multiple storage sites and, putatively, a 
neurotransmitter role, but its effects on brain blood 
vessels have not been adequately described. This 
thesis addresses several aspects of histamine's 
influence and location of activity in brain vessels.
The first part of the thesis deals with the effect of 
histamine on vascular permeability in brain. New 
quantitative methods were used to study the regional 
nature of response, and the types of histamine 
receptors involved. The second topic concerns 
cerebral blood flow. Dose-response relationships, 
regionality, receptor involvement, and relation to 
metabolic response were included in this section.
The third part of the thesis can be divided into two 
areas of investigation: an examination situ of 
pial arteriolar! and venous responses to histamine 
agents given by.'perivascular injection, an approach 
that provides information on cerebral vascular smooth 
muscle responses to direct histaminergic stimuli; 
and a determination of the influence exerted by 
histamine receptors on noradrenergic responses in 
pial vessels.
The studies of this thesis', therefore, deal with 
four vascular loci at which histamine may influence 
the cerebral circulation ^  vivo. 1) Vascular
permeability studies focus on events occurring at 
the endothelial cell level of brain vessels. 2) and
3) Blood flow and pial vessel studies involve the 
action of histamine at possibly two sites within the 
smooth muscle layer of brain arteries and arterioles.
4) Studies pertaining to the interaction of histamine 
with noradrenergic stimuli concern a possible 
influence by histamine at the nerve-smooth muscle 
junction in brain vessels. From these concepts is 
synthesised an hypothesis that proposes a differential 
distribution of histamine receptors within the 
cerebral vessel wall.
The lines of inquiry, data, interpretations, and 
concepts of this thesis evolved from my previous 
experiences and my own original experiments. This 
material has not been presented before as a thesis 
in any form.
CHAPTER I. INTRODUCTION 
Introduction I . Blood-Brain Barrier 
Concepts
Nearly a century has passed since the seminal studies 
of Ehrlich (62) who showed that a restrictive vascular 
interface to circulating blood solutes exists in the 
brain. Within the last fifteen years, morphological, 
physiological, and biochemical studies have been 
completed so that basic features of a blood-brain 
barrier are now familiar (reviews: 24, 27, 39, 43, 45, 78, 
175, 199). In general, blood constituents that are 
lipid-soluble rapidly reach equilibrium with endothelial 
cytoplasm and brain interstitial fluid (199, 200); lipid- 
insoluble substances, by contrast, passively diffuse 
across or between vascular endothelial cells by dissolv­
ing in aqueous phases in the endothelium (165, 199, 200). 
The rate of blood-to-brain transfer for lipid-insoluble 
particles approximates an inverse proportion to the 
molecular weight and hydrodynamic radius of the molecule 
(199, 200). Some substances, such as D-hexoses and 
L-amino acids, are transferred into the brain by special 
carriers (168).
Several unique characteristics associated with cerebral 
microvessels are 1) junctions between adjacent endothelial 
cells are tightly apposed and adhered by a matrix of fine 
fibres. In brain regions having barrier properties, 
there are no endothelial fenestrations; 2) there is 
normally a low level of contractile activity; 3) 
pinocytosis and vesicular transport are present but 
normally unimportant; 4) the mitochondrial density is 
relatively high; 5) regulatory enzymes are present in 
the endothelial cytoplasm; and 6) binding sites for 
neuro-transmitters are located within the endothelium. 
Because each of these functions may be influenced by, or be 
related to, a neurohumoral stimulus such as histamine, I 
will discuss relevant points in the following paragraphs.
Continuous bands of closely apposed endothelial cells
provide the unique characteristic of brain microvessels. 
These "tight" intercellular junctions have widths of 
about 12 A (27, 78, 199) which physically limit the 
passage of plasma solutes having hydrodynamic radii 
greater than 5 A (27, 199). Cell-to-cell mucoprotein 
adhesions may provide additional hindrance to inter­
cellular diffusion (78, 180). These junctional gaps 
of endothelial cells in brain correspond to the small 
pore system of vessels in peripheral organs. Estimates 
of small pore widths in skeletal muscle capillaries are 
40-100 A (204). In brain microvessels, however, the 
widths of intercellular junctions may not be uniform 
throughout the entire microcirculation. Because 
metarterioles (181, 241) and, presumably, venules, can 
transport protein into the brain under normal conditions, 
and because these vascular segments are involved in 
pathological disruption of the blood-brain barrier during 
some conditions (91, 160, 181), it may be more appropriate 
to refer to "microvascular" rather than only "capillary" 
permeability. In skeletal muscle, the small pore system 
in venules appears to be especially vulnerable to hist- 
amine-like mediators (114, 148, 212).
In some regions of the brain, there is no vascular 
barrier to circulating solutes, and blood vessels are 
characterised by wide intercellular clefts and fenestrae 
(24, 27, 78, 199). Brain structures and regions in 
this category include the choroid plexus, hypophysis, 
ependymal cells, median eminence, area postrema, and 
pineal gland (78, 199). These areas are relatively so 
small and circumscribed that their high permeability does 
not produce effects in the brain as a whole from agents 
in blood (24, 199).
Although brain endothelial cells have low contractile 
activity under normal conditions (199), mechanisms 
having the potential to mediate contraction are present. 
Two factors that may be important to contraction, and 
are present within brain endothelial cells, are ' 
histamine-sensitive adenylate cyclase (8, 121, 123, 125)
and myofibrillar filaments (134, 174, 180). Adenylate 
cyclase activity influences the energy level in the 
cell by synthesis of cyclic AMP (123, 158), and actin 
and myosin are linked to mechanical function (76).
Should these mechanisms be coupled in cerebral endo­
thelia, then cellular contraction could occur through a 
histamine stimulus. Endothelial contraction appears to 
be an important mechanism to the increased permeability 
seen in muscle and mesentery vessels during histamine 
administration (79, 124, 148).
Pinocytosis and vesicular transport normally operate at 
a low level in brain endothelia (199). Although factors 
influencing these functions are not yet clear, there is 
evidence to suggest that vesicular activity is mediated 
through receptors (84) and may be related to the energy 
level in the cell (242). Cyclic AMP may be a critical 
intermediate in a mechanism producing increased 
vesicular activity following stimulation by such factors 
as serotonin (242), acute hypertension (95, 119)*, vascular 
injury (210) and histamine (121, 123).
In electron microscopic studies, Oldendorf and co-workers 
(170) demonstrated that endothelial cells in brain 
capillaries had higher mitochondrial volumes than in 
peripheral organ capillaries. Possible functions related 
to this unique characteristic of brain endothelia are 
(170) 1) active transport of ions between blood and
cerebrospinal fluid; 2) extrachoroidal production of 
cerebrospinal fluid; 3) maintenance of the integrity 
of enzymes that regulate a barrier function; and 4) 
maintenance of the structural components of the blood- 
brain barrier. These last two mechanisms may be 
important to a histamine influence on cerebrovascular 
permeability. If histamine were to affect the energy 
level in endothelial cells, as discussed above, then 
histamine-sensitive enzymes, such as adenylate cyclase 
and, subsequently, vesicular activity, could be involved 
in a permeability change.
Two enzymes present in brain microvascular endothelia 
may be important in determining influences on 
permeability. Disposal of monoamines, such as dopamine 
(16), occurs through a degradative process involving a 
trapping and conversion function by dopa decarboxylase 
and subsequent catabolism by monoamine oxidase. This 
catabolic process is probably not important to histamine 
which is degraded principally by histamine-N-methyltrans- 
ferase (52). This enzyme is present in brain endothelial 
cells (125) , and is distributed widely throughout 
several brain structures (2 31). A second enzyme system 
that may be important to changes in cerebral micro­
vascular permeability involves the formation of cyclic 
AMP from ATP by adenylate cyclase (123), which can be 
influenced in cerebral capillary fractions by many bio­
genic amines (8, 113, 162).
Finally, recent ligand-binding studies have demonstrated 
the presence of histamine receptors in cortical micro­
vessels (179). Peroutka and co-workers showed that 
substantial levels of histamine, and adrenergic, 
receptors were present in both neuronal membranes and 
purified microvessels from bovine cortex (179). These 
results, therefore, confirm, and help to localise, the 
receptors for histamine previously identified in other 
neurochemical studies (220). Receptors at the plasma 
membrane of endothelial cells would represent the initial 
site for production of a permeability change by histamine.
Histamine
In qualitative studies published some thirty years ago, 
it was demonstrated that histamine could increase the 
passage from blood into brain of the dye, neutral red 
(115), and antibiotics, such as penicillin and strepto­
mycin (74). Studies since then have failed to confirm 
that histamine can influence the permeability of cerebral 
vessels (24, 81, 199), Factors that may account for 
confusion in the literature are the route and concentration 
of histamine administered, the duration of administration.
physical characteristics of the tracer used, and 
differences in responses between species.
Several characteristics associated with histamine, how­
ever, suggest that it should be among endogenous 
substances that influence cerebral vascular permeability. 
1) Histamine is a principal component of cerebral peri­
vascular mast cells (58, 99, 116, 117), which, when 
degranulated, could effect vascular permeability from 
the outside of the vessel (99, 117, 206). 2) Histamine
has been identified within the smooth muscle layers of 
brain blood vessels (67). This source of histamine 
could be liberated to influence endothelial permeability.
3) Histaminergic nerves are present in the brain (85, 
220); if these nerves have vascular terminals, then 
activation of neural pathways could affect vascular 
permeability. 4) Histamine-sensitive enzymes are 
present within cerebral microvessels (8, 125). Enzymes 
linked to cyclic nucleotide formation, such as adenylate 
and guanylate cyclase, may be important to function of 
the blood-brain barrier during normal and pathological 
conditions (123). 5) Specific receptors for histamine
are located within cerebreal microvessels (179),
Histamine receptorsi located along the plasma membranes 
of cerebral endothelia would provide a site for binding 
by histamine in blood, or from the abluminal sources of 
histamine listed above.
In non-neural organs, histamine is clearly a potent 
mediator of increased permeability. Histamine-induced 
increases in vascular permeability to a variety of 
substances have been measured in skin (207), skeletal 
muscle (48, 72, 90, 212), and the mesentery (79, 124).
It is not clear, however, by what mechanisms histamine 
produces its effect in these circulations. Widening 
of interendothelial pores (14 8, 157), increasing the 
number of pores per unit surface area (48), increasing 
the surface area (10), or stimulating vesicular transport 
(11, 203) are possible responses evinced by histamine.
Methodology
There are several methods available for the study of 
blood-brain barrier function. In general terms, these 
techniques can be categorised as either histological 
or physiological approaches to the measurement of 
vascular permeability in the brain; advantages and 
disadvantages in the use of several current methods 
have been reviewed recently by Blasberg (2o). In this 
section, I will discuss techniques that have been used 
to estimate the influence of histamine on the blood- 
brain barrier, consider quantitative methods available 
for measuring blood-brain exchange, and introduce the 
technique used in the studies of this thesis.
Qualitative Methods. This technique is founded on
the use of a tracer molecule that would not, under
/
normal conditions, enter the brain from blood in signif­
icant amounts. The most common tracer, still used in 
contemporary research, is a dye, such as Evans blue, 
which binds almost completely to plasma proteins'. 
Appearance of the dye in brain tissue, therefore, reflects 
the extent of protein extravasation into the brain inter­
stitial space. This method was the first approach used 
to evaluate the influence of histamine on blood-brain 
barrier permeability (115); the dye, neutral red, was 
shown to enter brain tissue in mice after systemic 
injection of histamine. Studies at the same time by
TV
Foldes and Kelentei (74) indicated that histamine could 
increase the brain penetration of circulating anti­
biotics. More recently, dyes have been used to evaluate 
function of the blood-brain barrier during several 
interventions, such as the effect of hypertonic solutions 
injected into the carotid artery (35, 198), and the 
influence of sympathetic nerves during acute arterial 
hypertension (103).
The principal advantage of qualitative methods is that 
they provide the opportunity to visualise an effect on 
barrier function by the colour of the dye used (103).
These methods have the obvious disadvantage in that 
they are not accurately quantifiable.
Electron Microscopy. Probably the most significant 
advances in understanding the nature of the blood-brain 
barrier have derived from studies using the electron 
microscope. This method involves use of an enzymatic 
tracer, such as horseradish peroxidase, which is given 
systemically and visualised microscopically at the endo­
thelial cell level (202). The important concepts of 
"tight" interendothelial junctions and low vesicular 
activity in normal endothelium have evolved from this 
method (27, 202). The method has been extended to 
yield additional information concerning barrier function 
in pathological conditions. The appearance of coated 
vesicles in response to intravascular injection^of 
mineral chlorides (120), the opening of tight junctions 
in response to carotid injection of urea (2 6), and 
increases in numbers of endothelial vesicles following 
irradiation (205)', spinal cord compression (15), stab 
wounds (210), and systemic administration of hydrolytic 
enzymes (83) have been demonstrated with this technique. 
Electron microscopy offers the investigator the advant­
ages of determining endothelial cell responses to stimuli 
on a focal level with extensive descriptive capacity. 
Pinocytotic activity is quantifiable (15, 181, 205), and 
information about related organelles and structures is 
readily available in the micrographs. The method does 
not, however, allow for determination of the rates of 
tracer transfer. Furthermore it requires considerable 
time, experience and skill in processing and interpreting 
the material.
Labeled Compounds. Tagging of vascular solutes with 
radioactive labels has introduced two important advantages 
to studies of brain vascular permeability. First, 
changes in permeability can be regionally quantified; 
second, the use of solutes with different molecular 
weights offers the potential advantage of discernihg
different routes of passage into the brain. For 
example, low molecular weight solutes (small hydro- 
dynamic radius), such as sodium (MW = 23; 21, 106, 138) , 
and noradrenaline (MW = 168; 35) may pass through endo­
thelial cell junctions and via vesicular transport, 
whereas larger particles, such as albumin (MW = 69x10^) 
may enter the brain only through vesicles (241).
Studies using these methods have) characterised regional 
permeability to changes to interventions such as drug- 
induced seizures (142) and carotid injection of hyper­
tonic urea (35). The main disadvantage of this method 
is that rates of solute transfer into the brain have 
not been quantified.
Intra-carotid Injection Methods. Two methods involving 
simultaneous injection of test and reference substances 
into the carotid artery have added considerable inform­
ation to the blood-brain barrier literature. In the 
method of Crone (37, 38), brain extraction of the test 
solute is compared to a nondiffusible reference tracer 
from the concentration of these substances appearing in 
cerebral venous blood after arterial injection. Many 
measurements are possible in the same preparation, and 
the method can be applied to humans (132), Because 
samples of blood are obtained from easily exposed blood 
vessels representing the arterial and venous circulations, 
the method does not provide values for regional permeab­
ility. This technique has been applied to yield the 
first measurements of vascular permeability in human 
brain during seizures (21) , extraction of water (177) , 
and penetration of lipid-soluble and carrier-mediated 
substances (108).
The brain uptake method of Oldendorf (167-169) compares 
the brain concentration of test Solute with a freely 
diffusible reference tracer following arterial injection. 
This method is technically simple, and many animals can 
be processed in a short period of time. In recent years, 
the technique has been critically evaluated and modified
to include corrections for use of the reference tracer, 
^H-water (169) , an intravascular component of radio­
activity (169) , -injection volume (93) , and circulation 
time following injection of the tracer mixture (93). A 
disadvantage of the method is that it provides only a 
measure of uptake of test solute, rather than a quantit­
ative determination of permeability. This technique 
has been used extensively, and many important concepts 
concerning brain entry of amines, sugars, amino acids 
and steroids have evolved (167, 168, 175, 176).
Brain Tracer Washout. By initially loading the 
brain vascular compartment with a moderately permeable 
tracer, such as labeled water or alcohols, blood-brain 
barrier permeability can be determined by measuring 
tissue clearance of the tracer, either by direct tissue 
sampling (23) or by external scintillation detection 
(63). In the studies by Bradbury et al. (23), brain 
tracer concentrations were determined at various times 
after carotid injection of several test substances to 
describe washout curves; as only one measurement can 
be obtained from each animal, this technique has the 
disadvantage of requiring several animals to provide 
one data point. This limitation is overcome by the 
method using external detection of radioactivity. 
Eichling, Raichle and colleagues have demonstrated the 
dynamics of water permeability at cerebral microvessels 
during several interventions (6 3, 194-19 6). The method 
can generate multiple washout curves from one animal, 
and it can be adapted for use in humans (19 6). There 
are several important disadvantages with this technique, 
however. Regional data cannot be derived, relatively 
large experimental subjects are required, such as 
monkeys or humans, it is difficult to correlate the 
external radioactivity with that in brain, and the 
isotope typically used, H 2 ^^0 , has a very short half- 
life (two minutes), requiring the co-ordinated use of a 
cyclotron.
Arterial Integral Method. This method involves 
intravenous administration of the test solute with 
subsequent arterial blood sampling to derive an integral 
of arterial radioactivity throughout the experiment.
Brain tracer concentration at the end bf the experimental 
period, divided by the arterial radioactivity over time, 
yields blood-to-brain transfer constants or permeability 
X surface area products that are more sensitive than 
those available using other techniques (20). Tracer 
may be administered to the animal by bolus injection 
(165) of by continuous infusion (44, 138). Tracer 
input by infusion has the limitation of leaving high 
intravascular isotope concentrations at the end of the 
study, leading to difficulty in separating brain from 
blood radioactivity. Also, it is technically cumber­
some to maintain arterial tracer concentration through­
out the experiment (44, 138). Accurate derivation of 
the intravascular radioactivity is also a problem in 
using the intravenous bolus method, but can be obviated 
by extending the experimental time period which allows 
for additional peripheral clearance of the tracer (201).
Other potential limitations of these techniques include 
reflux of the tracer from brain to blood, metabolism of 
the tracer by brain, and bulk flow of the tracer within 
the brain interstitial space. Back diffusion, or reflux 
does not seem to be an important problem because brain 
tracer concentrations are sufficiently low that a 
concentration gradient for tracer movement from brain to 
blood is negligible (19, 165, 201). Regarding tracer 
metabolism, appropriate test substances that are not 
metabolised by brain cells, such as sucrose (42, 137,
165), can be selected for this technique. Furthermore, 
bulk flow of sucrose is minimal within the time limit of 
the experiment because the measurable brain distribution 
volume is small (165).
As this method has several distinct advantages over 
other available methods, it was chosen to evaluate the"
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effects of histamine on brain vascular permeability 
in the studies of this thesis. The arterial integral 
method is quantitative, providing values for both 
permeability and intravascular volume on a regional 
basis (165, 201). The technique can be performed in 
small animals such as rats. The experimental period 
may be 10 to 40 minutes in duration (201), thereby 
averaging transitory changes in permeability and 
providing a representation of multiple passes of the 
tracer through the cerebral microcirculation. Several 
labeled substances could be used in this method (165).
The choice of solute, in fact, may provide useful 
information concerning the physiological process of 
blood-to-brain transfer of the substances. For example, 
in the present studies, sucrose and a neutral amino acid 
were chosen as test solutes; their physical properties 
are similar to those of endogenous neurotransmitters, 
e.g., they are lipid-insoluble, carried ifi suspension in 
plasma water rather than bound to proteins, are stable 
under physiological conditions, and are not actively 
transported by a carrier across brain endothelial cells 
(165).
Introduction II. Cerebral Blood Flow
The level of cerebral tissue perfusion depends on a 
number of local and systemic factors. Neural, 
chemical, and intrinsic autoregulàtoryinfluences may 
dictate the rate of blood flow within brain regions or 
in the central nervous system as a whole. Several 
reviews, presenting an integrated discussion of these 
factors, have been published (32, 59, 96, 129, 131, 133, 
192, 223, 224). Stimuli that may initiate or compound 
changes in cerebral blood flow can arise from alterations 
in the blood concentration of vasoactive amines (59) or 
from the metabolic demand by the brain (32, 87, 226) . A 
focus of the inter-relationship of these latter two 
factors formulates the topic of this section.
Concepts
Controversy concerning the effect of circulating amines 
on cerebral vascular smooth muscle and brain metabolism 
has been present in available literature for many years 
(59, 223, 224). Species differences and the several 
methods that have been applied may account for some of 
the discrepancies in results (59). Another factor 
appreciated only recently, however, is the integrity of 
the blood-brain barrier. Because most amines are lipid- 
insoluble and polar (168,199), their passage from the 
circulation to vascular smooth muscle or brain where an 
effect can be mediated is severely restricted under 
normal conditions (59). When the blood-brain barrier is 
circumvented, however, the true vascular or metabolic 
effect of the particular amine becomes evident (147).
The above mechanisms, and relevance of the blood-brain 
barrier to their expression, were first demonstrated for 
the neurotransmitter substance, noradrenaline, by 
MacKenzie and co-workers (144, 145). Noradrenaline is 
a potent constrictor agent in peripheral blood vessels 
(1, 76), but, during carotid arterial infusion, it has 
no effect in the cerebral circulation when the blood-
brain barrier is intact (145). MacKenzie et al. demon­
strated that transient disruption of barrier mechanisms 
by carotid injection of a hypertonic solution of urea 
allowed access of infused noradrenaline to brain; under 
these conditions, increases in both cerebral oxygen 
consumption and the blood flow were observed, suggesting 
that the infusion had produced, primarily, an increase 
in brain metabolic rate through the calorigenic action 
of noradrenaline (14 5).
Subsequent studies with other agents combining barrier 
disruption with carotid drug infusion were to identify 
theretofore undescribed metabolic and vascular responses 
in brain. In general, the evidence would suggest that 
most agents that alter cerebral blood flow following 
disruption of the blood-brain barrier do so by producing 
first an effect on brain metabolic rate. Substances 
in this category are 5-hydroxytryptamine (9 8), prosta­
glandins E2 and F 20C (183) , phenylethylamine (153) , and 
vasoactive intestinal peptide (154). Dopamine and 
tyramine, which are probably degraded by enzymatic 
catabolism in cerebral endothelia during normal conditions 
(16, 174), may also be in this group of substances; but, 
their effects in the cerebral circulation have not been 
evaluated ±n conjunction with blood-brain barrier 
opening (151, 152). Amphetamine (150) and the dopamine 
agonists, apomorphine (151) and piribedil (155), appear 
to readily enter the central nervous system from blood, 
and are associated with marked increased in cerebral 
oxygen consumption and blood flow.
Some substances that have been examined produced larger , 
changes in cerebral blood flow than in the index used to 
represent the metabolic response, usually either oxygen 
uptake or glucose consumption. Although inadequacies in 
methodology may account for these discrepancies in 
responses, it is possible that the agents may produce 
only a small effect, or have no influence, on brain metab­
olism, but have considerable stimulating effects directly
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on vascular smooth muscle. Prostaglandins (182, 185), 
piribedil (155), and acetylcholine (105) are in this 
class of substances that may be principally of vascular 
nature.
Histamine
The effect produced by histamine in the cerebral 
circulation is still a matter of controversy despite 
interest that spans decades (77, 224). In an older 
review (224), and in more recent papers (52, 135), 
histamine had been reported to be a potent dilating 
agent in the brain circulation. Dilatation resulting 
from intravascular administration of this amine is 
difficult to understand, however, because histamine 
itself is impermeable at the blood-brain barrier (168).
In the last 10 years there have been several studies 
that reported an increase in cerebral blood flow 
resulting from histamine infusion. Critical appraisal 
of these reports, however, reveals the following 
potential limitations: 1) flow measurements were
obtained from large extracranial vessels supplying the 
brain (217, 228), and may not accurately reflect 
parenchymal blood flow; 2) studies using perfused 
brain (159) or venous outflow (33) techniques require 
extensive preparatory surgery. Consequently, data from 
these experiments are probably not reliable (59, 102,
19 3); and 3) cerebral blood flow responses determined 
in dogs and cats (3, 33, 159, 217) are difficult to 
assess because the carotid vascular anatomy in these 
species is complex, possibly leading to errors in 
interpretation (118).
It is clear from the literature (171) that several 
characteristics of vascular response to histamine have 
been identified in peripheral organs but not in the 
brain. The role of the blood-brain barrier in 
determining what effect is produced by histamine in the 
cerebral circulation has not yet been examined. If
histamine were to evoke changes in cerebral blood flow, 
the regional nature of the response, the specific 
types of histamine receptor stimulated, and metabolic 
influences produced by this amine would constitute new 
information in the field. These questions were 
addressed in the studies of this part of the thesis.
Methodology
Although there are several methods available for 
measuring cerebral blood flow in experimental animals 
(59, 193, 223), not all of the techniques have been 
adapted for studies in small animals, such as the rat. 
Reliable determinations of total or regional cerebral 
blood flow in rats have not been, or can not be, made 
from such techniques as venous outflow, isolated 
perfusion, electromagnetic flowmetry, or probe-detected 
gas or heat clearance. Four methods have proved useful 
for measuring blood flow in rat brain. These include 
the Kety-Schmidt and intracarotid injection techniques, 
which involve measurement of gas clearance from brain, 
and the radioactive microsphere and diffusible indicator 
methods, which involve fractionation and determination 
of tracer concentrations in brain regions.
Development for studies in rats of the Key-Schmidt 
method by Siesjo and co-workers (65, 164, 22 3) and the 
intracarotid gas injection method by Hertz et al. (107) 
has added important experimental advantages to the 
determination of blood flow and metabolic responses in 
rat brain. Of major importance is the facility with 
which to measure blood flow several times in the same 
rat; these methods, therefore, permit the determination 
of control blood flow and responses to successive 
stimuli during one experiment. Simultaneous evaluation 
of oxygen consumption iS'possible using these methods 
(107, 223). The methods have the limitations, however, 
of requiring rather extensive surgical preparation of 
the animal. In the Kety-Schmidt method, a represent­
ative cerebral vein must be cannulated; in the intra­
carotid injection method, carotid artery and scalp 
surgery are required. As both of these techniques 
involve gas clearance from brain, blood flow must be 
assumed to be in a steady-state at the time of measure­
ment. Furthermore, particularly with the intracarotid 
injection method, there may be neuropathological damage 
resulting from multiple injections into the internal 
carotid artery (88). Control measurements of blood 
flow with these techniques, which reflect primarily 
cortical perfusion (65, 107, 110), are about 1.0 ml 
min ^ g”  ^with the Kety-Schmidt method (65, 164), and 
between 1.4 and 1.6 ml min”  ^ g"”^  with the intracarotid 
injection method (88,107). Values for the two methods 
are different because the intracarotid injection 
technique, by determination of flow from the initial 
slope of gas clearance (107), more closely represents 
the richer perfusion in cortical grey matter (110). 
Because the intracarotid injection technique permits 
several determinations of blood flow in one animal, and 
because this method was extensively evaluated during 
pilot studies for the thesis (88), the technique was 
applied in the present studies to characterise blood 
flow responses to histamine. A technique was required 
to evaluate possible regional responses in brain to 
histamine. Both the microsphere and diffusible indicator 
methods allow for assessment of flow on a regional 
basis by either tissue sampling (112, 166) or auto­
radiographic (216) determination. The theory and 
application of particulate (109, 149, 213) and diffusible 
(80, 127, 128) indicators for blood flow measurement 
have been thoroughly described.
With the radioactive microsphere method, a bolus of 
spheres is injected into the heart, distributed accord­
ing to the partition of the cardiac output, and, because 
the spheres are too large to pass through microvessels, 
they lodge primarily at the metarteriolar level (109).
Up to five determinations of cerebral blood flow can be
made in large animals, such as dogs (149). In rats, 
however, the technique has proved to be technically 
difficult (112) and small sample sizes from rat brain 
may undermine the sensitivity of the method. Further­
more, the microsphere method has not been properly 
evaluated for application to small animal brain as it 
has in dog brain (149), and in other organs (86, 109). 
Questions concerning appropriate sphere size, arterio­
venous shunting, and neuropathology need to be answered 
before this technique can be accepted as a reliable 
method for cerebral blood flow measurement in rats.
Blood flows for cortex obtained from microspheres in 
the studies of Horton et al, (112) were 1.0 to 1.3 ml 
j^in“ l g “ l.
The diffusible indicator method, which depends on the 
principles governing exchange between blood and brain 
of inert substances (127), has been applied to measure 
regional cerebral blood flow in large and small animals 
(80, 216). By obtaining thin sections of brain after 
systemic administration of the tracer, and exposing 
these to film, measurement of blood flow in very small 
brain regions can be determined by densitometry (216). 
This approach has the major disadvantage, however, of 
requiring several days for data processing, and involves 
the use of expensive, sophisticated equipment. A 
simpler approach, which yields less data but is based on 
the same principles, is to determine blood flow in macro­
scopic brain regions dissected by direct sampling of the 
tissue. This technique has been used previously to 
measure brain blood flow in rats with the tracers 
^^C-ethanol (66) and ^^G-iodoantipyrine (112, 166). 
Whether the data are derived by autoradiography or by 
tissue sampling, however, the diffusible indicator method 
can provide only one measurement of blood flow in a 
single animal. In anaesthetised rats, this technique 
gives blood flow values for cortex of 1.0 to 1.2 ml min”  ^
g"^ (112).
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The diffusible indicator technique, using the tracer, 
iodoantipyrine, was applied in the present studies 
for three reasons. First, the method is based on 
sound principles (127, 216); it has been shown that 
values for cerebral blood flow, obtained with iodoanti­
pyrine, are similar to those derived from use of 
radioactive gas (216). Second, the technique provides 
regional blood flow data to complement the studies 
using the intracarotid gas injection method, which does 
not yield accurate data for regional perfusion. Third, 
regional blood flows determined by tissue sampling 
represent a compatible technical approach to data 
derivation in the blood-brain barrier studies. Compar­
isons of blood flow and vascular permeability responses 
determined from tissue sampling may provide additional 
insight to the regional effect of histamine in the 
cerebral circulation.
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Introduction III. Pial Vessels in Situ
To study further effects of histamine in the cerebral 
circulation, experiments were undertaken to evaluate 
the response of pial arterioles and veins to specific 
stimulation of histamine receptors by pharmacological 
agonists. Three approaches were followed: 1) to
determine responses of pial arterioles to perivascular 
injection of histamine and its and H 2 receptor 
agonists; 2) to determine respones of pial veins to 
stimulation of histamine receptors; and 3) to examine 
how these receptor mechanisms might apply iqi vivo, 
studies were conducted to determine the interaction 
between histaminergic and noradrenergic stimuli.
Concepts
Examination of exposed pial vessels is one of the oldest 
quantitative methods used in brain vascular research. 
Experiments reported by Forbes and co-workers 52 years 
ago (77) provided an important foundation for the 
development of several concepts (224). Three manipul­
ations have mainly been used to provoke changes in pial 
vessel calibre; vasoactive drugs have been given intra- 
vascularly, drugs have been administered perivascularly, 
or endogenous mechanisms have been stimulated, such as 
by nerve activation or by altering arterial pressure. 
Determination of pial vascular responses to intra- 
arterial ox.-intravenous drug administration has not been 
very helpful generally because it is not known to what 
extent circulating agents penetrate the blood-brain 
barrier. Observation of a pial arteriolar response 
during intravascular drug infusion, for example, may be 
explained by direct stimulation of vascular smooth muscle 
(the drug penetrated the blood-brain barrier) or may 
arise secondarily from changes in systemic arterial 
pressure. It is not clear how permeable vascular 
endothelia are at the level of arterioles and veins. 
Enzymatic mechanisms may be absent in large brain vessels 
(16), but a structural barrier is probably present in
pial arterioles (144, 241).
Determination of pial vascular responses to perivascular 
administration of vasoactive solutions is an attractive 
experimental technique for characterising sensitivity 
to specific stimuli. A large number of studies 
concerning the vascular effects in exposed brain 
vessels of several chemical and autonomic stimuli has 
been reviewed recently (131). For studies of histamine, 
this approach has three important advantages: 1) peri­
vascular injection of histamine agents mimics the route 
by which histamine may influence brain vascular tone in 
vivof either by release from mast cells (58, 116) , or 
by activation of histaminergic nerves, which may have 
vascular terminals (85, 220); 2) it is possible that
histamine has a metabolic influence on neurones (85), 
and that alteration of their metabolism may affect brain 
vessels. The perivascular injection technique, however, 
obviates this potential problem; and 3) injection of 
histamine onto the outside of blood vessels may 
provide information regarding the vascular orientation 
of histamine receptors. There is evidence from studies 
using rabbit ear arteries vitro (82), that a pre­
dominance of histamine H 2 receptors may exist on the 
outside of blood vessels. Comparison of responses to 
stimulation of histamine receptors, as determined in 
other parts of this thesis, is important to the form­
ulation of hypotheses concerning the spatial distribution 
of histamine receptors within the cerebral vascular wall.
An important limitation in studying pial vessels is that 
no information about cerebral blood flow is gained. In 
response to drugs, changes in pial vascular calibre may 
not accurately represent-the response of intraparenchymal 
vessels which are more important to the regulation of 
brain perfusion (208).
The capability of histamine to interact with, and 
modulate, noradrenergic activity can be examined 
readily in the exposed pial vessel preparation by
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ombining perivascular injection of histamine agents 
ith stimulation of noradrenergic effector mechanisms, 
i. dense innervation of sympathetic fibres in pial 
vessels exists, extending throughout the hemibrain 
from the ipsilateral superior cervical ganglion (173). 
Modest pial arteriolar and venous constriction results 
from stimulation of sympathetic nerves (7, 130, 240). 
Concentration-response curves to perivascular injection 
of noradrenaline in arterioles have been determined by 
Wahl and Kuschinsky (130, 235, 237). There is no inform­
ation concerning noradrenaline effects in pial veins.
Histamine
Very few studies have been reported describing pial 
vascular responses to histamine. In the earliest 
experiments using the exposed brain technique, Forbes 
and his contemporary colleagues (77, 224) measured pial 
artery calibres during systemic administration of 
histamine. Their results cannot be properly interpreted, 
however, because histamine produced changes in arterial 
pressure which would affect pial artery responses. A 
number of studies involving histamine responses, as 
reviewed by Sokoloff (224) , can be similarly criticised.
Differences in the manner in which histamine has been 
introduced to the pial vasculature have produced con­
flicting results. In studies involving superfusion of 
histamine over the entire cortical field, Raper et al.
(19 7) found increases in arteriolar calibre in cats, 
and Rosenblum (209) found no effect on cortical vessels 
in mice. It is possible that histamine may have 
produced effects on cerebral metabolism which masked 
vascular responses in these studies. The superfusion 
technique does not seem appropriate for examination 
of histamine or other agents that might affect both 
neuronal metabolism and vascular smooth muscle. When 
histamine is administered by perivascular injection, pial 
arterioles always respond with dilatation which is 
concentration-dependent (238), As determined from
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studies using histamine receptor blocking agents,
the dilatation produced by histamine in pial arterioles
is mediated almost exclusively by H 2 receptiors (238).
What response veins have to histamine ix vivo is an 
important determinant to capillary blood flow, pressure 
and filtration, as discussed for peripheral organs by 
Haddy, Diana and associates (46, 47, 49, 89). Studies 
in peripheral vascular beds of vasoactive agents, 
including histamine, indicate that the precapillary 
resistance vessels are generally more responsive to 
these stimuli than capacitance vessels (46, 221), and, 
in fact, the vascular segments may have the opposite 
responses to the same stimulus (89, 221). In skeletal 
muscle and skin preparations, histamine may constrict 
(89, 189) or dilate (46, 47) veins. These findings 
collectively imply that such factors as vascular wall 
structure, wall tension, receptor distribution within 
the vessel wall, and receptor density may be important 
to differences in response to histamine between arteries 
and veins. In the only study to date in which brain 
arterial and venous responses to drug stimulation have 
been compared, vasoactive intestinal peptide produced 
significant dilatation of arterioles, but responses in 
veins were not different than those produced by the 
injection vehicle (154).
Interaction of Histamine With Noradrenergic Mechanisms
Histamine is synthesised and/or stored in autonomic 
nerves (214). It is richly concentrated in post­
ganglionic sympathetic nerves (214), and is avidly 
sequestered by sympathetic axons in rabbit iris (61). 
Although not yet demonstrated histochemically, these 
findings suggest that histamine may be present in 
cerebro-vascular sympathetic nerves,.and may play a role 
in modulating nervous activity at the sympathetic neuro­
effector junction. Using rabbit basilar arteries in 
vitro, Bevan et al. (17) showed that histamine could 
modify vascular responses to transmural nerve
stimulation and exogenous noradrenaline. Similar 
responses have been found in the dog saphenous vein 
(156), rabbit ear artery (73), and rabbit ganglia (28)
In vitro. In each of these studies, a potentiating 
effect of histamine on noradrenergic responses, linked 
to the class of receptors, was identified. The 
organisation and function of histamine receptors at 
sympathetic nerve endings appear to be complex because 
H2 receptors, in contrast to the cla'ss, inhibit 
adrenergic mechanisms in heart (141)^ blood vessels (156, 
191) and ganglia (28). How several transmitter 
substances may affect neurotransmission has been 
discussed by Brimble and Wallis (28) and Starke et al. 
(229) .
Methodology
Two methods currently in use to study brain surface 
vessels dqi situ are the open skull method of Wahl et al. 
(236) and the cranial window preparation of Levasseur 
et al. (1*36). The methods differ technically in two 
ways: in the open skull technique, the brain is
exposed, and is irrigated with mineral oil. The cranial 
window method involves use of an air-tight glass canopy 
under which artificial cerebrospinal fluid is circulated. 
In recent studies by Navari et al. (163), the two methods 
were critically and extensively evaluated. Their 
analysis indicates that the open skull method may be 
vulnerable to loss of carbon dioxide by diffusion from 
the brain surface, rendering the preparation unphysiolog- 
ical and leading to enhanced vascular responsiveness to 
some stimuli. Responses to arterial hypercapnia and 
superfused noradrenaline were greater in the open skull 
preparation, but there were no differences in vascular 
responses in the two methods during arterial hypotension 
(163). Although the importance of a stable concentration 
of carbon dioxide and H+ ion is recognised (131), it 
seems that the open skull preparation of Navari et al. 
did not satisfactorily replicate the depth of oil over
the brain as produced by Wahl et al. (236) and others 
who have adopted this method (146, 154). A thin 
layer of oil (1-2 mm) as used by Navari et al. would 
permit gas diffusion, while more oil (10-20 mm) 
probably reduces this problem. Measurements of pH 
in the subarachnoid space by Wahl's group (218) indicate 
that there is not measurable loss of carbon dioxide 
during typical experiments. Furthermore, prolonged 
and complicated studies using the open skull method have 
been performed with no appreciable loss in vascular 
responsiveness over several hours (146). Another 
difference between the two techniques is the extra- 
vascular pressure, which, in the cranial window method 
was established at 5 itimHg, and, in the open skull method, 
was at, or slightly above, zero. This difference, 
however, appeared not to be a factor in determining 
vascular responses (163).
The mode of drug delivery in the two methods would appear 
to be an important difference in choice of technique.- 
In the cranial window method, vasoactive agents are 
perfused over the brain surface (197); if these drugs 
also affect neuronal metabolism, then it would be 
difficult to discern vascular responses. For this 
reason, the cranial window method was deemed unsuitable 
for studies relating to histamine. In the open skull 
method, vasoactive agents can be administered by peri­
vascular micro-injection, which limits the volume of 
agents being studied and would not be expected to reach 
brain tissue in sufficient concentration to influence 
cellular metabolic rate (235). The principal limitation 
to this approach is that it is difficult to determine 
the extent or duration of receptor stimulation from the 
drug injected.
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Introduction IV. Histamine Receptors.
Histamine is an autocoid with ubiquitous distribution 
in mammalian tissues. Within the first decade (1910- 
1920) of investigation into physiological and patholog­
ical mechanisms that involve histamine, it was 
recognised, primarily through the efforts of Dale (41) , 
that this amine was important to inflammatory and 
anaphylactic phenomena. Other mechanisms, reactions, 
and substances now known to be related to histamine 
include allergies and hypersensitivity syndromes, pain 
and itch, tissue response to injury, tissue growth and 
repair, systemic response to venoms and toxins, autonomic 
control of the circulation, cluster (Horton's) headache, 
and mast cells and basophils; Excellent reviews 
concerning the early history of histamine research, 
and extension of physiological understanding of this 
amine, have been published by Douglas (52), Beaven (13) 
and Rossi (211) .
Recognition of responses mediated by histamine prompted 
considerable pharmacological development of agents that 
could inhibit its activity. In 1948, Folkow and co­
workers (75) demonstrated in cats that histamine- 
induced depressor responses were only partially 
attenuated by mepyramine (pyrilamine), a prototype 
among many histamine antagonists available at that time. 
These findings led the authors to believe that there 
may be two kinds of histamine receptors in blood 
vessels (75). This concept was given further 
description through the studies of Ash and Schild (6) 
who characterised several biological responses to 
histamine. These investigators identified responses 
that could be blocked by mepyramine, and related anti­
histamines, as effects mediated by an Hj class of 
receptors; non-Hp receptors (defined later as H 2 
receptors) mediated responses to histamine that were 
refractory to mepyramine. Synthesis of the first 
histamine H 2 receptor antagonist, burimamide, emprged 
from the exhaustive tests over eight years by Black 
and associates (18) of Smith, Kline and French
ZD
Laboratories.
With the concept and pharmacological entity of two 
distinct receptors for histamine being established, 
it is now possible to categorise many physiological 
phenomena as or H 2 receptor responses (171, 219). 
Specific stimulating or blocking agents have been 
developed to examine various mechanisms (13, 52, 54,
55, 211).
Prototype receptor response: contraction of extra- 
vascular smooth muscle.
receptor agonists: histamine, 2-methylhistamine, 2,2 
pyridylethylamine, 2,2-aminoethylthiazole,
receptor antagonists; mepyramine maleate, 
diphenhydramine.
Prototype H 2 receptor response: stimulation of gastric 
acid secretion.
H 2 receptor agonists; histamine, 4-methylhistamine, 
dimaprit, impromidine.
H 2 receptor antagonists: burimamide, metiamide, 
cimetidine.
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CHAPTER II. PROCEDURES
General Surgery and Animal Preparation,
Rats
Experiments were performed with male Sprague-Dawley 
rats weighing 275 to 425 g . Anaesthesia was induced 
with 3% halothane in oxygen, the trachea was cannulated, 
and mechanical ventilation with 0.4% halothane and 
N 2O-O2 (70-30%) was used to maintain anaesthesia.
Skeletal muscle paralysis was achieved with gallamine 
triethiodide (10 mg kg ^h ^ , iv), and heparin (750-1000 
U kg iv) was used for anticoagulation.
Polyethylene catheters were placed in both femoral 
arteries and veins for continuous measurement of 
arterial pressure, for withdrawal of arterial blood, 
and for administration of drugs and tracers. Arterial 
blood gases and pH were determined frequently.
Corrections for arterial PCO2 and pH were made by 
adjustments in tidal volume or by intravenous injection 
of sodium bicarbonate (8.4%). Body temperature was 
maintained at 37 - 0.5 c»C by external heating.
In most experiments, a catheter was inserted retro- 
gradely into the external carotid artery, and advanced 
to the origin of the internal carotid artery. I 
ligated remaining arterial branches near the carotid 
bifurcation, including the large pterygopalatine 
artery which branches from the internal carotid artery 
(100, 106). In other studies, an additional catheter 
was inserted into the right axillary artery, and 
advanced retrogradely through the subclavian artery to 
the brachiocephalic trunk. Correct positioning of 
the catheter in the subclavian artery was verified by 
injection of Evans blue (about 50 pi), and by 
immediate appearance of the dye in the common carotid 
artery. The external carotid and subclavian artery 
catheters, therefore, provided access for drug
zo
administration to the brain via the common and 
internal carotid arteries. In the rat, the internal 
carotid artery does not have anastomoses with extra- 
cranial structures distal to the pterygopalatine 
artery (100). Drugs were administered into the 
internal carotid artery by constant pump infusion at 
a rate of 4 5 pi min"^.
Some of the experiments required dissection of the 
rat brain at the end of the study. The intact brain 
was removed from the skull, and dissection was 
completed with a small curved scalpel blade. Topol­
ogical landmarks, described by Zeman and Innes (246), 
were followed to obtain bilateral samples of hypo­
thalamus, thalamus, caudate nucleus, hippocampus, 
frontoparietal cortex, and three samples of cerebrum. 
Cerebrum samples were comprised of parts of the 
hemisphere remaining after the discrete structures  ^
listed above were removed. Midbrain, pons, medulla, 
cerebellum, and, for one study, cerebellar cortex, 
were also obtained. Samples weighed from 12 mg 
(hypothalamus) to 175 mg (cerebrum).
In experiments requiring measurement of brain and 
arterial blood radioactivity, the samples were placed 
in either glass (for tissue) or plastic (for plasma) 
scintillation vials. One to two ml of Soluene was 
added to the vials containing tissue for maceration, 
and vials were heated in a water bath (50 ^C) until 
the samplè was dissolved. Acetic acid (2 N, 0.5 ml) 
was added to inhibit chemiluminescence, and 10 ml of 
scintillation fluid (Instagel) was added before the 
samples were placed in a cooled counter for scintill­
ation analysis. Samples were counted for four to 
ten minutes, depending on the level of radioactivity. 
Plasma samples from arterial blood, and Instagel, 
were combined in vials and counted for four minutes. 
Triplicate readings were obtained and averaged for 
each vial. Raw counts per minute were converted to
disintegrations per minute from a linear calibration 
curve using both external standardisation and the 
channels-ratio method for efficiency determination 
(178).
Cats
Mongrel cats of both sexes weighing 2-5 kg were used. 
Anaesthesia was induced by intravenous injection of 
Saffan (alphaxone, 6.75 mg kg  ^ and alphadolone 
acetate, 2,25 mg kg ). The trachea was intubated, 
and the cats were mechanically ventilated with air 
and oxygen to maintain arterial PO2 greater than 100 
mm Hg, and arterial PCO2 between 30 and 35 mm Hg. 
Anaesthesia was maintained by intravenous injection 
of alpha-chloralose in doses of 50 mg kg”^, given as 
needed during the study. Cannulae were inserted in­
to a femoral artery and vein, and were advanced to the 
descending aorta and inferior vena cava. Throughout 
the study, end-tidal CO2 , arterial blood pressure, 
and body temperature were measured continuously, and 
samples of arterial blood were frequently analysed 
for blood gas and pH determination. When required, 
skeletal muscle paralysis was achieved with gallamine 
triethiodide (10 mg kg“^h”^, iv).
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Methods I. Blood Brain Barrier Studies
For these studies, 108 rats were used, prepared as 
described above. In each set of experiments 
described in this section, saline or histamine was 
infused unilaterally into one internal carotid 
artery. Responses in the hemisphere ipsilateral 
to infusion were compared to the contralateral 
(control) side of the brain. I completed three 
series of studies which were designed to examine 
different aspects of the influence of .histamine on 
cerebrovascular permeability: 1) permeability
studies using sucrose. This series involved 
determination of dose-response relationships, 
reversibility, and the class of histamine receptor 
involved in mediating changes in permeability; 2) 
permeability studies using a neutral amino acid, 
alpha-arainoisobutyric acid. These experiments 
involved use of autoradiographic and densitometric 
techniques that permitted a more precise identific­
ation of brain regions in which permeability changes 
occurred; and 3) studies concerning brain water 
content to determine whether histamine caused oedema 
in brain.
Permeability to Sucrose
In these experiments (n = 70), saline or histamine 
was infused for 15 minutes into the internal carotid 
artery. Five minutes after the start of infusion,
10 pCi of ^^C-sucrose (165) in 0.5 ml saline was 
injected intravenously. For the next ten minutes, 
femoral arterial blood was sampled repeatedly. The 
samples were centrifuged, and 20 pi aliquots were 
removed and analysed for radioactivity to describe 
the history of arterial over the course of the
experiment (Figure 1). At the end of the ten minute 
blood sampling period, the rat was sacrificed and 
brain samples were obtained by dissection, and were 
weighed. In additional experiments, used to derive
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Figure 1. Derivation of arterial integral after
intravenous injection of radioactive sucrose. Blood 
samples (filled circles) were obtained from a femoral 
artery, and radioactivity was measured by liquid 
scintillation counting.
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estimates of intravascular volumes for the brain 
regions, the experiments were only two minutes in 
duration. Radioactivity levels were measured by 
liquid scintillation counting; brain samples were 
counted in duplicate for 10 minutes each, and plasma 
samples were counted in triplicate for four minutes 
each.
The method of analysis for quantitative measurement 
of brain vascular permeability is based on the theory 
of unidirectional transfer of sucrose from blood 
across endothelial cell membranes into brain extra­
cellular spaces (165, 201), Because sucrose is 
lipid-insoluble and polar (37, 42, 165, 199), its rate 
of transfer under normal conditions is very slow; 
likewise, because brain levels remain low, reflux of 
sucrose from brain back to blood can be regarded as 
negligible (165). Permeability x surface area 
products (PA) for sucrose were derived from the 
relationship (165):
dr
i/dt = PA ' Cp (1)
where = brain parenchymal tracer concentration at 
time t and Cp = arterial plasma tracer concentration. 
By integrating the above equation, the operational 
equation of the method derives:
Pfi = c. ( t)
;- dt (2)O ^
The amount of tracer in brain (C\) was determined by 
correcting the total measured brain tracer concentrat­
ion for the amount of tracer estimated to be within 
the intravascular space^ The estimated vascular 
volumes from the two minute experiments, together 
with the final whole blood tracer concentration, 
determined this correction (165).
Estimates for blood volume were determined from two- 
minute experiments which were conducted for each series
o J
under conditions identical to the ten-minute studies. 
Brain tracer content in the two-minute experiments 
was converted to a blood volume estimate by correct­
ing for the amount of tracer estimated to be in 
parenchyma (165). This was accomplished by subtract­
ing from total brain tracer concentration the product
14of permeability and arterial C integral, as follows:
* . r  — *
C, (t) - PA ' I C dt
BV = w O P (3)
^b*
where: values denoted by * are obtained from the two-
minute experiment, and PA is determined from the ten- 
minute study. Cj^  indicates the final tracer concent­
ration in whole blood.
Dose-Response Relationship. To examine whether an 
increase in permeability was sensitive to:the ' 
concentration of histamine infused, four sets of 
studies were completed involving continuous infusion 
of saline or one of three doses of histamine, 2, 6, 
or 20 ^g min  ^ kg ^ . For the permeability studies, 
five, four, six and seven rats, respectively, were 
used for the four conditions; to estimate blood 
volumes, five, two, three, and five rats were used.
In rats in each of the groups, brains were dissected 
regionally and bilaterally to determine if responses 
were consistent from structure to structure, and to 
examine side-to-side differences.
Reversibility. Upon finding an increase in perm­
eability with histamine, I attempted to determine
whether the response was a reversible phenomenon.
-1 -1Histamine was infused for 15 minutes (20 ug min kg ) 
14but C-sucrose was not injected until 30 minutes or 
two hours after the end of infusion. For each of 
these conditions, five rats were used in the permeabil­
ity experiments, and three rats were used in the■
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estimation of blood volume.
Receptor Identification. To determine which
histamine receptors were involved in the permeability
response, separate groups of rats were pretreated
with either mepyramine maleate (H^ receptor antagonist)
or metiamide (H_ receptor antagonist) before histamine
-1 “1was infused (20 pg min kg ). Each antagonist was 
given intravenously lO minutes before the start of 
histamine infusion in a dose of 5 mg kg ^ . For 
mepyramine, six rats were used to determine permeabil­
ity responses, and three rats were used to estimate 
blood volumes; for metiamide, five and three rats 
were used for the two groups.
Permeability to Alpha-Aminoisobutyric Acid (AIB).
In these studies, saline (n=5) or histamine (n=5, 20
-1 -1 14pg min kg ) was infused for 15 minutes. C-AIB
(55 pCi in 0.8 ml saline) was injected intravenously 
five minutes after the start of infusion, and blood 
samples were obtained repeatedly over the following 
20 minutes. A 20 minute sampling period was 
required in these studies to allow intravascular 
tracer concentration to reach levels that were only 
a fraction (lessthan 6%) of brain concentration.
Blood volume estimates have not been incorporated in­
to this technique (19).
Samples of plasma were analysed for radioactivity by
liquid scintillation counting. Following sacrifice,
the brain was carefully removed and immersed in
isopentane at -50 ^C. Sections of brain were cut
coronally (20 pm thick) on a cryostat at -22 ^C, were
placed on cover-slips, and were dried on a hot-plate.
Autoradiographs -were made of the brain sections and
of plastic standards by exposure to film for 14
to 21 days. Optical densities were obtained using a
2
frame size of 0.09 mm on a densitometer. By refer­
ence to the plastic standards, optical densities could
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be converted to nCi units, which, with the arterial 
integral, were used to compute blood-to-brain 
rate constants (K^) for AIB (19) using the equation
"i ■
J
Brain Water Content
Twenty-eight rats were used to determine if changes 
in brain water content resulted from histamine 
infusion. Unilateral infusion of saline (n=14) or 
histamine (n=14, 20 pg min ^ kg was made for 15 
minutes. An additional five minute period followed 
the infusion to allow blood pressure to return to 
normal and stabilise before the rat was sacrificed. 
Brain regions obtained bilaterally were hippocampus, 
parietal cortex, cerebrum, and hindbrain, which 
included the brainstem and cerebellum. The brain 
samples were placed individually in tared aluminium 
trays, and were weighed within five minutes of being 
removed from the skull. The samples were placed in 
an oven at 50 for several days until desiccated. 
Percentage water content was then calculated from 
the dry and wet weights, and right and left regions 
were compared.
Jb
Methods II. Cerebral Blood Flow Studies 
133Intracarotid Xenon Clearance Technique.
Sixteen rats were used to estimate cerebral blood flow
133from the clearance of Xenon injected into the in­
ternal carotid artery (107). For these rats, a 
longitudinal scalp incision was made to expose the 
skull and temporal muscles, and the right temporal 
muscle and overlying skin were reflected. A fine 
needle, with an outside diameter slightly smaller 
than the inside diameter of the catheter in the 
external carotid artery, was inserted until its tip 
lay at the mouth of the catheter. The catheter and 
needle were secured in place with skin sutures, and 
the needle was connected to a microsyringe by a screw 
fitting.
A sodium-iodide scintillation crystal was placed over 
the exposed parietotemporal calvaria immediately 
ventral to the crista frontalis, and was angled (4 5^) 
to avoid extracranial sources of xenon, such as the 
trachea. The crystal, with an internal diameter of 
12 mm, was thickly collimated with lead to an aperture 
diameter of 4 ram. Other characteristics of the 
crystal, and its relationship to cranial landmarks, are 
shown in Figure 2. The crystal was coupled to a photo­
multiplier., a scaler and a ratemeter which integrated 
the counts with a one-second time constant. Output
-I
was recorded on chart paper at a speed of 1 cm sec
The pulse-height analyser was calibrated to the photopeak 
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of Xenon at 81 keV with a gate width of + 20%.
For each determination of cerebral blood flow, a 10 pi
133bolus (10 pCi) of Xenon was injected from the micro­
syringe over one second,and the washout was monitored 
continuously until it had decreased to about 40% of 
the highest count rate.
Cerebral blood flow was calculated from the initial
slope of a semilogarithmic plot of the clearance 
curve (107, 110) using the following equation:
CBF = (5)
where: CBF = cerebral blood flow in ml min  ^ g
= brain/blood partition coefficient for xenon in grey
matter of rat brain (0.80; 164); t, = half-time of
133 ^the Xenon clearance in seconds. Flow measurements
during normal conditions were possible every few
minutes because the rate of gas clearance was rapid
and background counts were minimal (less than 5% of
the highest count rate).
Arterial blood pressure and blood gases were measured 
at the time of each blood flow estimate. Cerebral 
vascular resistance was calculated by dividing mean 
arterial pressure by blood flow.
Three sets of studies were conducted to determine 
effects of intra-arterial infusion of histamine before 
and after disruption of the blood-brain barrier, and 
to evaluate the participation of specific histamine 
receptors.
First, histamine was infused into the axillary artery
catheter at a rate of 45 ul min and in a dose of 20 
-1 -1pg min kg . This dose was chosen because prelim­
inary trials with various doses of histamine indicated 
that higher doses produced arterial hypotension that 
may have exceeded the lower limit of autoregulation. 
Duplicate determinations of blood flow were made when 
arterial pressure had stabilised, usually about 5 
minutes after the beginning of histamine infusions.
Second, the blood-brain barrier was first disrupted 
by carotid injection of hypertonic urea (2M). This 
technique produces a transient increase in cerebro­
vascular permeability to circulating blood solutes 
^escribed in more detail below). Histamine infusion
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Figure 2. Schematic diagram of scintillation
crystal and its relationship to the rat
133head for external detection of Xenon 
after carotid injection. Characteristics 
of the crystal viewing area are shown.
was begun 10-15 minutes after urea injection, and
blood flow determinations were made 5 minutes later.
Histamine was infused in four concentrations: 2, 6,
-1 -120 and 60 pg min kg , and duplicate measurements 
were obtained at each dose. If the values did not 
differ by more than 10%, they were averaged; if 
there was variability in the duplicated measurement, 
the first determination was accepted. In some rats, 
it was necessary to inject a second bolus of urea so 
that additional blood flow determinations could be 
secured. Preliminary studies indicated that two 
injections of urea in the same animal did not have 
deleterious effects on the preparation.
Third, because higher doses of histamine produced
increases in cerebral blood flow after blood-brain
barrier opening, I administered one of two histamine
receptor antagonists before histamine infusion, but
after injection of urea (to assure similar opportunity
for the antagonists to reach cerebrovascular smooth
muscle and brain). Mepyramine maleate (H^ receptor
antagonist) or metiamide (H„ receptor antagonist) was
-1given intravenously (each 5 mg kg ) to test for 
effectiveness in blocking histamine-related increases 
in cerebral blood flow. Measurements of flow were, 
obtained during administration of ascending doses of 
histamine in animals treated with each of the blocking 
agents.
14C-iodoantipyrine
In 34 rats, measurements of regional cerebral blood
flow were obtained by systemic administration of 
14C-iodoantipyrine and regional dissection of fresh 
brain. A method using this tracer for autoradiographic 
determination of cerebral blood flow in conscious rats 
has been published recently (216). lodoantipyrine is a 
diffusible substance at cerebral vessels with a brain 
tissuerblood partition coefficient of 0.79 (216).
Values for cerebral blood flow obtained with this tracer
are similar to those derived from the radioactive 
gas, iodine-labeled trifluoroiodomethane (216). 
^^C-iodoantipyrine (20 pCi in 1.5 ml saline) was infused 
intravenously during 30 second experiments on a "ramp" 
schedule, i.e.,the rate of infusion was increased 
progressively so that arterial tracer concentration 
would be highest at the end of the experiment. This 
infusion schedule was used to provide optimal conditions 
for separating rates of blood flow between high and 
low flow structures. During administration of the 
tracer*arterial blood was allowed to drip freely from a 
partially occluded catheter in the femoral artery, and 
12 to 18 samples of blood were obtained separately on 
preweighed filter discs. The times of sampling were 
recorded and were used with the radioactivity concent­
ration of each blood sample to describe the history 
of arterial radioactivity during the experiment. The 
rat was killed by decapitation immediately at the end 
of tracer infusion, the brain was removed, and 
regional samples were dissected and placed in tared 
scintillation vials for weighing. The brain and blood 
samples were then processed for liquid scintillation 
counting to determine radioactivity levels. Brain and 
blood samples were each counted for four minutes. 
Computations of blood flow for the brain regions were 
performed according to the equations of Kety (128) as 
applied by Sakurada et al. (216):
K = Ci(T) (6)
t)dt
where: C\(T) is the tracer concentration in the brain 
sample at a given time, T; ^  is the brain:blood part­
ition coefficient; is the concentration of tracer 
in arterial blood; t is time; and K is a constant that 
incorporates the rate of blood flow per unit weight of 
tissue.
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The assumptions in using iodoantipyrine for measure­
ment of cerebral blood flow are satisfied because 1) 
equilibration between the tracer and tissue is limited 
by delivery, not by diffusion; 2) arterio-venous 
shunts in the brain microcirculation are either not 
present or not important; and 3) small regions of brain 
have relatively homogenous levels of perfusion (80,
216) .
Three sets of paired experiments were conducted: First,
control measurements of blood flow were obtained in rats
which had only the carotid artery surgery performed (no
drug infusion). Additional studies were completed in
-1 -1rats given histamine infusion (20 jig min kg ) into
the internal carotid artery, but without blood-brain
barrier disruption by urea injection. Second, urea was
first injected to disrupt blood-brain barrier mechanisms,
then, 15 minutes later, saline or histamine (20 ug min 
-1
kg ) was infused into the internal carotid artery
catheter. Third, comparisons in response were made
between rats infused with the histamine receptor agonists,
either 2,2-pyridylethylamine (H^) or dimaprit (H_) (each 
- 1 - 1200 yjg min kg ) following carotid injection of urea.
All substances infused into the internal carotid artery 
were dissolved in saline and given at 4 5 ^1 min ^.
Because histamine given by intracarotid infusion produced
arterial hypotension, which, due to autoregulatory
mechanisms, might interfere with vasodilator responses,
I examined blood flow responses in three additional
rats whose blood pressure was maintained by aortic
occlusion. In these animals, both axillary arteries
were used for measuring blood pressure and for sampling
arterial blood during the experiment, and histamine 
-1 -1(20 p.g min kg ) was infused via a catheter in the
external carotid artery. I placed a ligature around 
the descending aorta at the level of the diaphragm, 
lodoantipyrine was infused via a catheter in either the
jugular or axillary vein. During infusion of hista­
mine, when arterial pressure decreased, an assistant 
gently pulled on the ligature to occlude the aorta 
and maintain arterial pressure at levels approximat­
ing normal.
14C-2-deoxyglucose
Sixteen rats were used to determine whether carotid 
arterial infusion of histamine increased the rate of 
glucose utilisation in the brain. ^^C-2-deoxyglucose 
(10 pCi in 1 ml saline) was injected intravenously and 
arterial blood was sampled repeatedly over the follow­
ing 30 minutes. From the plasma of each blood sample, 
a 20 pi aliquot was obtained to determine the radio­
activity concentration in the blood sample, and a 15
pi aliquot was used to measure the glucose concentrat-
-1 -1ion. Either histamine (20 pg min kg ) or saline 
was infused continuously throughout the experiment.
The infusions were begun 10-15 minutes following carotid 
injection of urea. Continuous infusion of the agents 
was applied to provide a "constant" stimulus, which is 
one of the assumptions of the deoxyglucose method (225).
At the end of the 30 minute blood sampling period, the 
rat was killed, and brain samples were obtained by 
dissection, were weighed, and were analysed for radio­
activity concentration by liquid scintillation counting. 
Samples were counted for four minutes. Derivations of 
glucose consumption in each brain region were computed 
according to the equations of Sokoloff et al. (225).
Blood-Brain Barrier Disruption
Because vascular endothelia in the cerebral circulation 
may form a barrier to circulating histamine or its 
agonists, a method was needed which would disrupt 
barrier mechanisms without damaging the brain. A 
technique involving use of hypertonic solutions injected 
into the carotid circulation has been devised by 
Rapoport and co-workers (198, 201) and extended for use
in baboons and rats by Pickard, MacKenzie and co­
workers (60, 145, 147, 184), One ml of 2M urea 
(filtered and warmed to 37 ^C) was injected into the 
carotid artery over 30 seconds. This technique has 
been shown previously in rats to increase brain 
vascular permeability to noradrenaline (60,92), and 
to maintain an open barrier for at least 30 minutes 
(94) .
In preliminary studies, I examined the effect of
hypertonic urea injection on cerebral blood flow by
13 3using the intracarotid Xenon technique, which 
permitted serial measurements of blood flow over the 
space of several minutes after urea was given. These 
studies demonstrated that brain blood flow was trans­
iently increased by 15-20% for approximately 15 
minutes after urea. This phenomenon of increased 
cerebral blood flow following urea injection has been 
confirmed in rats by other investigators (93). All 
intracarotid drug infusions in my studies were begun, 
therefore, 15 minutes after injection of urea to avoid 
the complicating effects that urea had on the brain 
circulation.
In additional studies in four rats, cerebrovascular 
permeability to labeled sucrose was determined after 
intracarotid urea injection. These studies were 
designed to quantify the extent of blood-brain barrier 
opening using the urea injection technique. ^^C- 
sucrose (10 pCi in 1 ml saline) was injected intraven­
ously 10 minutes after urea, and arterial blood was 
sampled for the following lO minutes when the rat was 
killed for brain sampling. Brain and blood samples, 
and calculations for regional permeability x surface 
area products were evaluated as described above in 
Methods I. Estimates for blood volumes were taken 
from the data of Ohno et al. (165),
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Methods III. Pial Vessels in Situ
The methods- in this section are adapted from the 
original technique of Wahl and associates (236).
Thirty-two cats were used for these experiments. The 
head of the cat was positioned in a stereotaxic frame, 
and a longitudinal incision was made along the scalp.
Skin, fasciae and muscle were cleared from the bone 
and retracted with ligatures onto a metal ring so that 
the skin formed a pool over the skull. Using a dental 
drill cooled with saline, I made a craniectomy measur­
ing 2 x 1  cm over the parietal calvaria. The exposed 
dura and skull surface were then bathed in heated 
mineral oil (liquid paraffin) which flowed continuously 
across the surgical field at a depth of 15 mm. A 
thermistor positioned near the craniectomy permitted 
the constant monitoring of bath temperature which was 
maintained at 37-38°C throughout the experiment, I 
cut the durai membrane along the borders of the 
craniectomy and controlled bleeding with strips of 
oxidised cellulose.
The field was illuminated with fiber optic lights and 
visualised with a stereomicroscope at x40 or x70 
magnification. The image of vessels viewed was 
passed through a television camera mounted on the 
microscope and displayed on a television monitor in 
the laboratory. The diameter of a given vessel could 
be determined from an image-splitting device (9) 
connected to the microscope and television camera. The 
amount of shear of the image was recorded continuously 
on à strip-chart; the degree of shear required to 
appose tangentially the split images of a vessel was 
directly proportional to the size of the vessel.
Filaments of known diameter were used to calibrate the 
system before each study.
Several pial arterioles and veins were selected randomly 
at the beginning of each experiment. At normal arterial 
pressure (between 90 and 120 mmHg), the resting diameters
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of the vessels in these studies were in the range of 
35 to 260 pm.
Drugs were made fresh the day of each experiment.
Mock cerebrospinal fluid (CSF) was used as the solvent 
vehicle for the injection solutions. Composition of 
the mock CSF (in mM) was: NaCl 144; 3; Ca^^ 5;
HCO^”* 12. pH was adjusted to 7.18. The drugs used
in these experiments were histamine dihydrochloride,
2,2-pyridylethylamine, (H^ receptor agonist), impromidine
(H2 receptor agonist), mepyramine maleate (H^ receptor 
antagonist) and noradrenaline. Glass pipettes with 
tip diameters of 8-10 pm were filled with the agents 
and mounted on a micromanipulator. The position of 
the pipette tip could be precisely controlled and was 
placed through the arachnoid membrane into the peri­
vascular space of the selected vessel. Approximately 
3 pi of fluid was injected and resulting changes in 
vascular calibre were followed for up to 12 minutes.
The observed changes in vascular diameter were express­
ed as a percentage change from the preinjection control 
diameter of the vessel.
Two series of experiments were completed using this 
method.
Perivascular injection in arterioles and veins
In these studies, several does of the histamine agents 
were injected to determine dose-response relationships 
in both arterioles and veins. Vessels were selected 
randomly, and there was no order of the dosages used 
for a particular drug. In some cases, a given vessel 
was used for subsequent injections but there was 
always a period of a least 30 minutes between two 
injections.
Noradrenergic stimulation
In these studies a bipolar- platinum electrode was 
positioned on the cervical sympathetic nerve trunk on 
the same side as the surgery. During stimulation, 
the electrical parameters were 15V, 2ms, 20 Hz.
4 0
Stimulation was verified as effective when the ipsil- 
ateral nictitating membrane retracted and the pupil 
showed marked dilatation.
When sympathetic stimulation was examined in the 
presence of histamine agonists, the protocol was 
designed to examine first the response of the vessel 
to nerve stimulation. Vascular diameters were 
recorded between 30 and 45 seconds after the start 
of stimulation. The stimulator was turned off, and 
the vessel was allowed to recover. Measurements were 
taken to verify when the vessel had returned to control 
diameter. Usually, this period was 2-3 minutes. The 
pipette containing the histamine agent was then position­
ed next to the vessel, the stimulator was turned on, 
response of the vessel to stimulation was checked on 
the television monitor and the eye, and the drug was 
injected. Measurements were recorded beginning at 30 
seconds after the start of stimulation, and were 
continued for the following 15 seconds. Comparisons 
were made between the vessel diameter before stimulat­
ion (control), during stimulation, and in the presence 
of the histamine agent during stimulation.
In studies involving simultaneous application of the^ 
histamine agents with noradrenaline, the solutions were 
made to their respective designated concentrations 
and were combined in the same pipette. The final 
concentration of the individual agent in the pipette 
was corrected for volume. Comparisons were made 
between the responses to the agents alone, and their 
response in combination.
Statistical Analysis
Data'Were anâiysed.by several statistical procedures. 
Matched and independent comparisons by t-test, one-and 
two-way analysis of variance, Scheffe and Dunnett 
multiple comparison tests, and nonparametric tests 
were performed as described by Steel and Torrie (230),
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Winer (244) and Siegel (222). In all cases, a 
minimum level of significance was accepted at 
p ^  0.05.
Drugs and Tracers
Several pharmacological agents and radioactive tracers 
were used in these studies. Because molecular weight 
(MW) may be an important consideration for some of 
the substances, the value in daltons is included 
where relevant.
Metiamide (MW = 244), 2,2-pyridylethylamine (MW = 194), 
dimaprit (MW = 234), and impromidine (MW = 4 31) were 
obtained from Smith, Kline and French, Welwyn Garden 
City, England. Mepyramine maleate (MW = 401) was 
obtained from May and Baker, Dagenham, England. Other 
drugs used were histamine dihydrochloride (MW = 184), 
(Sigma Chemicals, Dorset, England), urea (Hopkin and 
Williams, Chadwell Heath, England), heparin (Boots, 
Nottingham, England) gallamine triethiodide (May and 
Baker), alpha-chloralose (BDH Chemicals, Poole, England), 
and Saffan (Glaxovet, Greenford, England).
14Isotopes used were C-sucrose (MW = 342) (Radiochemical
14Centre, Amersham, England), C-alpha-aminoisobutyric
acid (MW = 103) (Radiochemical Centre), ^^^Xenon (Radio-
14chemical Centre), C-iodoantipyrine (New England 
Nuclear, Boston, Massachusetts), and ^^C-2-deooxyglucose 
(New England Nuclear).
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CHAPTER III. RESULTS
Results I . Blood-Braln Barrier 
Permeability to Sucrose
The values obtained for permeability x surface area 
products (PA) for several brain regions will be 
presented in the following tables. Values in the 
"non-infused" brain regions represent the PA product 
contralateral to the infusion, and, therefore, serve 
as the control for the experimental "infused" 
structure. Differences were calculated as (experim­
ental - control 7 control) x 100.
Dose-Response Relationship. Infusion of saline 
or histamine in various doses did not influence 
arterial blood gases, but, in the animals receiving 
histamine, arterial blood pressure was lower during 
the experiment (Table 1).
Unilateral carotid infusion of saline did not produce
any significant changes in regional PA products
(Table 1; Figure 3). Infusion of histamine in a low 
-1 -1dose (2 pg min kg ) was associated with no signif­
icant change in permeability in any brain region 
except hippocampus in which an increase of 33% occurred
(Table 1; Figure 3). At higher concentrations, ( 6 
"1 -1and 20 pg min kg ), histamine produced significant
increases in several regions in the distribution of
the middle cerebral artery. Structures affected were
thalamus, caudate nucleus, hippocampus, parietal
cortex, and cerebrum (Table 1), For the specific
grey matter regions, the range of permeability change
—1 —1was from 50 to 81% for 6 pg min kg , and from 70 to
-1 -1237% for 20 pg min kg (Figure 3). In regions in 
the distribution of the basilar artery, e.g., midbrain 
and cerebellum, there were no side-to-side differences 
(Table 1).
Measurements of blood volume from the two-minute
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Figure 3. Differences in permeability x surface area 
products (PA) for sucrose between non­
infused (left) and infused (right) brain 
regions during histamine infusion.
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experiments indicated that there was a tendency for 
histamine to decrease vascular volume in brain 
regions ipsilateral to infusion (Table 2). A 
significantly smaller blood volume was found only
“1
in cerebral cortex during infusion at the 20 pg min 
kg  ^ dose (Table 2).
Table 2. Effects of histamine infusion on regional
blood volumes (BV)
Regional BV 
(ml g  ^ X 100) Saline
Histamine 
(20 pg min ^kg"^)
1
Thalamus
L
2.6+0.3
R
2.5+0.3
L
2.1+0.5
R
1.5+0.5
Caudate nucleus 1.6+0.2 1.5+0.2 1.6+0.3 1.2+0.3
Hippocampus 2.1+0.3 2.5+0.3 2,0+0.3 1.6+0.3
Cortex 2.0+0.1 3.0+0.2 2.9+0.5 1.2+0.2*
Cerebrum 2.1+0.3 2.0+0.2 1.9+0.3 1.8+0.3
Midbrain 2.3+0-3 2.7+0.4 1.9+0.3 2.2+0.4
Cerebellum 3.2+0.3 3.0+0.3 3.0+0.4 3.0+0.4
Values are x + SE for 5 animals in each group, * p ^  
0.05. Histamine was infused into the right internal 
carotid artery for five minutes before the beginning 
of the experiment, and continuously throughout the 
two minute blood sampling period. l^C-sucrose was 
used as tracer (165).
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Reversibility. In these experiments, both groups 
of rats were allowed to recover from the histamine 
infusion before the permeability experiment was 
conducted. Arterial blood gases and pH were normal, 
and arterial blood pressure had returned to normal 
levels before the blood sampling was begun (Table 3).
In the rats allowed to recover for 30 minutes after 
the infusion, PA products were still higher ipsilateral 
to infusion in caudate nucleus, hippocampus, and cortex 
(Table 3). The range of increased permeability was 
from 62 to 95% (Figure 4). In thalamus, which had 
displayed an increased permeability during infusion, 
there was no difference between the infused and non­
infused side 30 minutes following infusion (Table 3). 
Likewise, there were no significant differences in PA 
between left and right cerebrum, midbrain and cere­
bellum (Table 3).
By contrast to the 30 minute post-infusion condition, 
at two hours after infusion, there were no regions 
which indicated a side-to-side difference in PA products 
(Table 3; Figure 4).
Receptor Identification. Administration of the. 
histamine receptor antagonists, mepyramine or metiamide, 
produced transient changes in arterial pressure which 
had stabilised before the permeability experiment was 
started. Arterial blood gases in both groups of rats 
were normal (Table 4).
Pretreatment with the receptor blocking agent, 
metfsiciide, prevented the increase in permeability seen 
in untreated animals (Table 4); there were no signific­
ant differences in PA products in any region examined 
(Table 4, Figure 5).
By contrast, pretreatment with the H^ antagonist, 
mepyramine, failed to alter the increase in permeability 
in all regions except hippocampus, in which there was
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Figure 4. Reversibility of permeability response
for sucrose following histamine infusion.
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Figure 5. Receptor involvement in permeability 
response for sucrose during histamine 
infusion.
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some attenuation of the permeability increase (Table 
4, Figure 5). In midbrain and cerebellum, there were 
no differences in PA products (Table 4).
Permeability to Alpha-Aminoisobutyric Acid (AIB)
In this series, using an autoradiographic method, 
optical densities in cortex were generally higher 
than in deep brain regions, such as caudate nucleus 
and midbrain. There was difficulty in identifying 
other brain structures because the brain concentration 
of AIB was low, and anatomical features were not high­
lighted in the autoradiographs. Identification of 
the structures presented was based on their relative 
location within the frontal plane.
Physiological measurements obtained within five min­
utes of the end of the experiment indicated that 
arterial blood gases and blood pressure in both 
groups were normal (Table 5). Blood pressures were 
lower in the histamine group probably because the 
animals had not fully recovered from the hypotensive 
effects of histamine.
Infusion of saline did not produce any significant 
differences in AIB transfer (%_) between the infused 
and non-infused hemispheres (Table 5). Infusion of 
histamine, however, did produce increases in in 
several regions of cerebral cortex. Visual, parietal, 
sensory-motor, frontal and olfactory cortices demonstrat­
ed increases in of 40 to 111% (p < 0.05, Table 5, 
Figure 6). In regions within the distribution of the 
anterior cerebral artery, e.g., rhinal and anterior 
cingulate cortices, K^s were increased similarly in both 
hemispheres (Table 5). In auditory cortex, caudate 
nucleus and midbrain, there were no significant increases 
in AIB permeability (Table 5), Also, there was no 
effect of histamine infusion in choroid plexus, which 
had relatively high transfer constants under normal 
conditions (Table 5).
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Figure 6, Regional effect of histamine on blood-
to-brain transfer of alpha-aminoisobutyric 
acid in cerebral cortex. S-M = sensory- 
motor cortex.
60
Brain Water Content
Arterial blood pressure and blood gases determined 
at the end of these experiments were normal (Table 
6) .
The sampled regions showed differences in water 
content from structure to structure: grey matter
structures, such as cortex and hippocampus, contained 
more water than did regions of mixed grey and white 
matter, such as brainstem and cerebellum (hindbrain)
(Table 6), In the rats infused with saline, there 
were no significant differences in water content 
between the infused and non-infused sides of the 
brain (Table 6). In the histamine group, water 
content was greater in cortex ipsilateral to infusion, 
but, in hippocampus, cerebrum or hindbrain, there 
were no side-bo-side differences.
61
V£>
A(d
EH
0)
c
1—1 
o
•H LO CD d 1—i
§ + 1 + 1 + 1 + 1
tn m o m 00
•H 1—t r—1 m m
M rH
S
«— f
o
CO CO o rH
+ 1 +  1 + 1 +  1
CO CD CT» cn
o\ Mt-1 ro m
taOt
<1<#p
ro rH rH
d d d d
+1 + 1 + 1 + 1
CN m CM 1—1
O 1—1 d d
m *00 rH CM
o O o O
+1 + I +1 +1
o 1—t CO CD
n 00 LOCO 00 r~
lO rH CN
O O o O
+ 1 + 1 4-1 4-1
o r~ CO
CN m <X) in
00 00
CPi CN 1—1
d d d d
4-1 4-1 4-1 4-1
CN CN H
o o o O
CTi
d
m
CD
CO
d
00
CTl
00
CO
o
+ 1 + i +1 +1
CO cn o  O
CO
cn cn (N r4
d  d  d  d
+1 +I +1 +1
O  CO 0> CTi
m
c(U
s
rd
tn 0)
tn 0) P
tn tn c
0) Id o
u CP Ü
A Cn P
■CJ CP m p1—1 o w 01 A
ftJ o p -H
■H 1—1 (d ÛJ cn
U A > > P<U A-P rH (N rH s •iHP (d CN o fd tn p (d
■H o K u P <Ll u X p P
p Ot A A 0 P o 0) A A
c <u *r4 cp A p <U fO
(d p CP A p P C
(U p <d dP •rj o 01 •H
s < A —' tn o U tn
o
p
c
•H
>1A
1—1
fd
p
Q)
P
fd
rH
■tH P
C o
P •Htn
T) PQJ p
tn p
p •H
p
p P
•H O
tn TO
p P
> P
0) P
p rP
•H P
rH
p Ptn P
P
p P
0 P
tn
rH p
I p
CP P
rX P
rH -H
1 E
P
•H LO
E TJ
A Pn
P. -H
O ■H
CN PU
P
W tn
P
•H p
p
p
P Stn
•iH tn
tn rHP
B•H
P
A P
P
o P
p Æ
A Eh
Xi
U
P
P tn
p
P P•H P
Ptn ‘H
1—1 EP
S LO
•H rH
P
P P
O
tp
1—t
>1
P P
0 P
UH P
P
P
w
w 'Ü
4-r+j
p p
p p
0> u
B
rH
0) P
p P
P P
P
tn P
p P
P ■H
rH
P P
> P
CP
■S
■g
o
&(UM
5u
2iw
+Js
siwU-J•HT3
>iiH
-PC(0U.4
"H
CP■HW
IT)
o
d
V
A
c
0•HW
•5
OJ
•H
I— 1
fdw
s
<uU)
§
S'(Uu
1 .
t i g
•PcQ)
a -
S 2
>1 W
(U tn 
P
•H 
It
c
g
o
V
A
62
Results II. Cerebral Blood Flow.
Quantification of Blood-Brain Barrier Disruption
Cerebrovascular permeability to labeled sucrose was 
evaluated after carotid injection of hypertonic urea.
The hemisphere contralateral to urea injection served 
as the control for these studies.
In brain regions contralateral to urea injection,
there was a range of permeability x surface area
-6 “1products of 7.8 to 12.6 x 10 sec . Ipsilateral 
to urea, there was a substantial increase in sucrose 
penetration to the brain. Results, expressed as 
ratios of ipsilateral/contralateral, were; caudate 
nucleus: 4.2; hippocampus: 4.5; cerebrum: 4.6; 
thalamus: 3.9; and medulla: 1.3
Responses to Histamine: Xenon Clearance
-1 -1Intracarotid infusion of histamine (20 /ag min kg )
decreased arterial pressure from 104 to- 79 mmHg, but
did not alter cerebral blood flow when the blood-brain
barrier was intact (Table 7). At doses greater than 
-1 -16 p.g min kg , histamine significantly reduced
cerebral vascular resistance (Table 7). After urea,
-1 -1infusion of histamine in a low dose (2 min kg )
did not significantly increase cerebral blood flow,
-1 -1but higher concentrations (6, 20, 60 yyg min kg ) 
were effective (Table 7). The increases in blood 
flow produced by these higher doses of histamine were 
27 to 50% above pre-infusion control levels of flow 
(Figure 7).
Additional flow measurements were obtained during 
histamine infusion after intravenous administration 
of the specific histamine receptor antagonists, 
mepyramine maleate (H^) or metiamide (Hg) (Table 8). 
Histamine was infused at the doses which produced 
increases in blood flow before receptor blockade. The 
blood-brain barrier was disrupted with urea before the
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Figure 7. Cerebral blood flow responses ( Xenon 
clearance) to histamine infusion before 
and after blood-brain barrier (BBB) 
disruption,
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administration of antagonist and histamine. Both 
antagonists attenuated blood pressure and blood flow 
responses to histamine (Table 8); metiamide was more 
effective.
Responses to Histamine and its Receptor Agonists: 
lodoantipyrine
In control animals, there were no significant side-to- 
side differences in blood flow in any brain region 
(Table 9). Infusion of histamine (20 pg min  ^kg 
in animals not given urea to disrupt the blood-brain 
barrier also did not produce side-to-side differences 
in blood flow (Table 9). In additional studies 
designed to examine whether the arterial hypotension 
caused by histamine was important to the blood flow 
result, I found that when arterial pressure was 
maintained near control levels during histamine infusion, 
there were no effects on blood flow in the ipsilateral 
hemisphere. Blood pressure before histamine infusion 
in three rats was 118+13 mmHg; during infusion, it was 
93+13 mmHg; and, 30 seconds after the start of the 
experiment during histamine infusion and aortic
occlusion, blood pressure was 115+7 mmHg. Blood flow
"  -1 -1 in the non-infused cerebrum was 1.34+0.09 ml min g ,
and, in the cerebrum ipsilateral to histamine, blood
flow was 1.26+0.09 ml min ^ g
Following carotid injection of urea, infusion of 
saline was associated with no change in regional cerebral 
blood flow (Table 10); there was a tendency for blood 
flow to be lower in several regions ipsilateral to 
infusion, but these differences were not significant 
(p >  0.05, Table 10). Administration of histamine 
after blood-brain barrier disruption, however, produced 
significant increases in blood flow in hypothalamus (+9%), 
thalamus (+10%), parietal cortex (+31%), and cerebrum 
(+9%) (Table 10). There was a tendency for blood flow 
to be increased in caudate nucleus and hippocampus, but 
these changes did not attain statistical significance
67
(p ^  0,05, Table 10). In regions not perfused 
primarily by internal carotid artery blood, such as 
brainstem and cerebellum, there were no significant 
side-to-side differences in blood flow during hista­
mine infusion (Table 10).
Carotid infusion of the histamine receptor agonists, 
pyridylethylamine (H^) andi.dimaprit (H^) , after urea 
injection, produced significant flow increases in 
several brain regions (Table 11, Figure 8). Stimul­
ation of receptors by pyridylethylamine was 
associated with increased blood flow in hypothalamus 
(+29%), caudate nucleus ( +20%), parietal cortex (+35%), 
and cerebrum (+10%) (Table 11). Dimaprit evoked 
increases in blood flow (range of +12 to +29%) in all 
territories examined in the distribution of the middle 
cerebral artery (Table 11).
Effect of Histamine on Glucose Consumption
-1 -1Saline or histamine (20 pg min kg ) was infused for 
30 minutes into the internal carotid artery following 
carotid injection of urea. Regional brain glucose 
consumption was measured by the 2-deoxyglucose method 
and tissue sampling.
Neither agent produced any regional or side-to-side 
change in the rate of glucose consumption (Table 12, 
Figure 9). Some of the regional values were lower 
in the animals given histamine; this effect may have 
arisen because of the prolonged infusion of histamine 
(30 minutes) which probably stimulated release of 
catecholamines from adrenal tissue, and increased levels 
of circulating glucose. Higher blood glucose concent­
rations occurred in the animals given histamine, and 
this result may explain the lower values for glucose 
utilisation in the histamine%infused rats.
To establish whether the method could detect changes in 
glucose consumption, two additional animals were 
given an intra-carotid infusion of noradrenaline (6 pg
68
min kg ) after blood-brain barrier disruption by 
urea. Noradrenaline produced an average increase 
in glucose utilisation in caudate nucleus and 
parietal cortex by 31% and 43%, respectively; in mid­
brain, there was no effect of noradrenaline infusion.
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Figure 8. Comparison of cerebral blood flow 
responses (lodoantipyrine) to histamine receptor 
agonists after blood-brain barrier disruption. 
PEA = pyridylethylamine.
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Figure 9. Effects of histamine infusion on regional 
cerebral glucose consumption after 
disruption of the blood-brain barrier.
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Results III. Pial Vessels in Situ.
Responses to Perivascular Injection of Histamine and 
Its Agonists.
Arterioles
Perivascular injection of mock cerebrospinal fluid 
(CSF) had no significant effect on arteriolar 
diameter (% change from control = -24-2%, n = 82 
vessels in 30 cats.
Responses to histamine were established over a 
range of four doses from to 10“"^ m . Small
dilatations resulted at doses of 10"^^ and lO^^M but 
responses were greater at 10“  ^ and 10"^^ (Figure 10).
The maximum response demonstrated with histamine 
occurred at lO-'^M (2 8% increase in vessel diameter 
from control).
The receptor agonist, pyridylethylamine, was studied 
at five concentrations between 10“ and 10“3m . This 
drug produced only weak dilatatory responses at all 
doses examined. The threshold for dilatation with 
pyridylethylamine was at 10“^M (10% increase in calibre), 
and the maximum response occurred at 10“^M (17%) (Figure 
10).
Six concentrations of the H2 receptor agonist, iraprom- 
idine, were studied. This drug produced significant 
dilatations of arterioles at concentrations as low as 
1Q-I0jy[ (1 6 % increase in vessel calibre). The maximum 
dilatation produced by impromidine occurred at lO^^M 
(43% increase in vessel calibre) (Figure 10).
Because impromidine proved to be an active and potent 
drug at pial arterioles, a further analysis was 
completed to describe a possible relationship of vessel 
size to magnitude of response. At the concentrations 
producing the largest increases in vessel calibre (lo”  ^
to lor^M, n = 31 vessels), there was no significant 
relationship between initial vessel size and the 
magnitude of response that resulted from impromidine. 
However, when vessel responses were partitioned between
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the lowest size limit (<80 yam) and the highest size 
limit ()>155 pm) , there was a tendency for difference 
with regard to size and response. Small vessels 
had an increase in vessel calibre of 45+4% and large 
vessels had an increase in vessel calibre of 35+4%
(n = 9 each).
Veins
Veins did not respond significantly to perivascular 
injection of mock CSF (+4+2%, n = 15 vessels in six 
cats).
For each of the histamine agents,venous responses were 
examined at two concentrations. For histamine itself, 
there was no significant effect on venous calibre at 
either of the concentrations studied. At 10 and 
10 M, vein responses to perivascular injection were 
2% and 4%, respectively (p> 0.05 with respect to pre­
injection control calibre of the vessel) (Figure 11).
For the receptor agonist, pyridylethylamine, which
-5 -3was studied at concentrations of 10 M and 10 M, 
responses were 1% and 5%, respectively (p> 0.05) 
(Figure 11).
Similarly, impromidine, the receptor agonist, did 
not produce significant changes in venous calibre. 
Responses to 10 and 10 were 0% and 5%, respect­
ively (p> 0.05) (Figure 11).
Interaction with Noradrenergic Stimuli 
Sympathetic Stimulation
Six sets of experiments were conducted using 12 cats 
in this series. Sympathetic nerve stimulation was 
studied for its effect on both arterioles and veins 
in the presence of histamine, pyridylethylamine, and 
impromidine.
77
% Change From 
Preinjection 
Control 
Diameter
SE
^Threshold p<0 OS
Mean
IMPROMIDINE ( H g )
HISTAMINE
2 5 - -
PYRIDYLETHYL AMINE
-10- 1 2 .-81010 10
MOLAR CONCENTRATION
Figure 10. Effects of histamine agonists on the 
calibre of pial arterioles. Numbers 
Represented: impromidine = 60 vessels
in 11 cats; histamine = 40 vessels in 
14 cats; pyridylethylamine = 42 vessels
/
in 13 cats.
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Figure 11, Effects of histamine agonists on the 
calibre of pial veins. Responses in 
veins are contrasted with the maximal 
response found in arterioles. Numbers 
represented: histamine = 15 veins in 4 
cats, 15 arterioles in 7 cats; 
pyridylethylamine = 24 veins in 5 cats,
12 arterioles in 5 cats; impromidine =
30 veins in 5 cats, 17 arterioles in 6 cats
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Arterioles
Sympathetic nerves were stimulated before each trial 
with a histamine agent. Before histamine was 
injected, stimulation of sympathetic nerves produced 
a decrease in arteriolar calibre of -6% (n = 8)
(Figure 12). In vessels not under stimulation, and 
at concentrations of 10 M and 10 M, histamine 
produced dilatations of 22% (n - 12) and 31% (n = 5), 
respectively. During sympathetic stimulation, 
injection of histamine in these same doses produced 
dilatations that were considerably smaller than 
before stimulation. Vessel responses to the two 
doses were +7% (n = 7) and +11% (n = 6), respectively 
(Figure 12).
Before injection of pyridylethylamine in 10 arterioles,
sympathetic stimulation produced a mean decrease in
vessel calibre of -6% (Figure 13). Pyridylethylamine,
-5 -3
in doses of 10 M and 10 M, produced dilatations of
11% (n = 8) and 21% (n = 9) (Figure 13). In the
presence of nerve stimulation, these responses were
-5not changed. At 10 M, there was still an increase
in vessel size of 12% (n = 6); at 10 ^M, there was a
mean dilatation of 20% (Figure 13).
Prior to injection of impromidine, sympathetic stimul­
ation reduced vessel calibre by -11% in 16 arterioles 
(Figure 14). At doses of 10 and 10 ^M, impromidine 
increased vessel calibre by 12% (n = 13) and 36% (n =
8), respectively (Figure 14) . During nerve stimulation, 
the constriction normally seen during sympathetic 
stimulation was abolished by simultaneous injection of 
impromidine. Vessel calibres were increased by 13%
(n — 6) and 28% (n = 5) for the two concentrations, 
respectively (Figure 14).
Veins
In veins, I studied sympathetic nerve influences on 
vessel calibre before and during administration of only 
one concentration of each histamine agent. Before 
histamine in 11 vessels, stimulation of nerves
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Figure 12. Effects of histamine on responses of pial 
arterioles to noradrenergic stimuli.
Values are mean + SE; see text for 
number of vessels and cats. HA = histamine; 
SS = sympathetic nerve stimulation; NA - 
noradrenaline. *p-C 0.05 for comparison of 
vessel response between individual and 
combined stimuli.
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Figure 13. Effects of pyridylethylamine (PEA, 
agonist) on responses of pial 
arterioles to noradrenergic stimuli. 
Abbreviations and symbols as in Figure 
12.
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Figure 14. Effects of impromidine (IMP, H2 agonist ) 
on responses of pial arterioids to nora­
drenergic stimuli. Abbreviations and 
symbols as in Figure 12.
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produced a 9% decrease in vessel calibre. Histamine,
-6
in a dose of 10 M, increased vein calibre by 2%
(n = 9). When combined, constriction of the veins 
was not seen; a 5% increase in venous calibre was 
observed (n = 11) (Figure 15).
Before pyridylethylamine, sympathetic stimulation
produced a constriction of veins by -8% (n = 8)
— 5
(Figure 16). In a dose of 10 M, pyridylethylamine 
increased vessel calibre by 1% (n = 13). During 
sympathetic stimulation, pyridylethylamine prevented 
the constriction (+4% change in vein calibre, n = 8) 
(Figure 16).
Before impromidine was given, stimulation decreased 
vein calibres in 9 vessels by -14% (Figure 17).
There was no change (0%, n = 14) in vessel calibre 
when impromidine (10 ^M) was given. When combined, 
however, the constriction seen with nerve stimulation 
was prevented by impromidine (+1% change in vessel 
calibre, n = 9) (Figure 17).
Noradrenaline
The effects of noradrenaline were examined alone and 
in the presence of each of the histamine agents in 
both arterioles and veins.
Arterioles
Arteriole responses to each of the histamine agents 
alone were the same as in the series involving 
sympathetic nerve stimulation.
-4Noradrenaline (2.5 x 10 M) was given perivascularly
by itself before each of the histamine agents. Before
histamine, noradrenaline produced a mean decrease in
vessel calibre of -18% in nine vessels (Figure 12).
When combined with histamine in two doses (10 and 
-410 M ) , vessel calibres showed small increases (+4% 
and +11%, respectivelyj each n = 12) (Figure 12)
Before pyridylethylamine, noradrenaline injection
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produced reductions in arteriolar diameter by -22%
(n = 9) (Figure 13). In the presence of pyridylethyl­
amine, the noradrenaline constriction was only partly
“5attenuated. At 10 M, vessel response to the two 
drugs was -10% (n = 9); at 10 ^M, the response was 
-14% (n = 8) (Figure 13).
For the group of vessels in which responses to
impromidine were examined, noradrenaline produced
constriction of -22% (n = 7) (Figure 14). When
combined, the noradrenaline-impromidine mixture
-8produced a -1% change in vessel calibre at 10 M
impromidine (n = 18), and an 18% increase in vessel
-6diameter with 10 M impromidine (n = 8) (Figure 14). 
Veins
Vein responses to each of the histamine agents alone
were the same as in the sympathetic stimulation series.
-4The same dose of noradrenaline (2.5 x 10 M) was given 
perivascularly to veins alone and in combination with 
one concentration of each of the histamine agents.
In the histamine experiments, noradrenaline produced a 
mean decrease in vessel diameter of -18% (n = 11) 
(Figure 15)- When combined with 10 histamine, the 
mixture containing noradrenaline produced a decrease 
in vessel calibre of -15% (n = 11) (Figure 15).
Before pyridylethylamine, a reduction in venous calibre 
of -13% (n = 8) was produced by noradrenaline. In 
combination, the mixture produced a decrease in vessel 
diameter of -20% (n = 8) (Figure 16).
In the impromidine studies, noradrenaline by itself 
decreased vessel calibre by -13% (n = 8). When given 
together, the noradrenaline-impromidine mixture 
produced a decrease in vein calibre of -Ï2% (n = 8) 
(Figure 17).
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Figure 15. Effects of histamine on responses of 
pial veins to noradrenergic stimuli. 
Abbreviations and symbols as in Figure 
12.
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Figure 16. Effects of pyridylethylainine (PEA^  
agonist) on responses of pial veins to 
noradrenergic stimuli. Abbreviations 
and symbols as in Figure 12,
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Figure 17. Effects of impromidine (IMP, agonist) 
on responses of pial veins to nora­
drenergic stimuli. Abbreviations and 
symbols as in Figure 12.
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CHAPTER IV. DISCUSSION
Discussion I . Blood-Brain Barrier.
Intra-arterial infusion of histamine produced an 
increase in permeability of the blood-brain barrier. 
Several new concepts emerged from these studies: 1)
the increase in permeability was sensitive to the 
concentration of histamine administered; 2) the 
permeability of several brain regions was increased;
3) the increase in permeability due to histamine was a 
reversible phenomenon; 4) histamine receptors 
were predominantly responsible for the permeability 
effect; and 5) the increase in permeability was 
associated with formation of oedema in grey matter.
In this discussion, I will focus on six points that 
encompass the above characteristics of the permeabil­
ity alteration produced by histamine in brain vessels: 
the regionality of the response; the reversibility 
of the phenomenon; receptor involvement; the magnitude 
of response; possible mechanisms to explain the 
change in permeability; and implications the studies 
have for blood-brain barrier responses under various 
conditions ijr vivo.
Regionality
During histamine infusion, increases in permeability 
to sucrose occurred in several brain structures 
(Table 1) and, as demonstrated by the AIB studies, 
several regions of cerebral cortex were affected 
(Table 5). Permeability increases within relatively 
homogeneous tissue, i.e., cerebral cortex, were 
variable (Table 5). The effective concentration 
of histamine, and anatomical factors related to drug 
delivery and receptor distribution in the cerebral 
microcirculation, may account for these differences.
Concerning the concentration of histamine in the 
microcirculation, it is difficult to calculate or argue
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how a relatively higher concentration reached areas 
such as caudate nucleus and cerebral cortex where 
the largest increases in permeability occurred.
These regions are highly vascularised (246) which 
could explain a permeability change based on a larger 
surface area for contact at endothelial cell layers 
by histamine. Furthermore, there may be hetero­
geneity of vascular metabolic activity within different 
brain regions (36) , viz, vessels in grey matter may 
have a higher metabolic rate than vessels in mixed 
regions or in white matter. Intrinsically, therefore, 
vessels in structures such as caudate nucleus and 
cerebral cortex may have a greater capacity to react 
to stimuli in the blood.
Two anatomical factors may account for regional 
differences in the permeability response to histamine. 
First, arterial "boundary" zones, where late-gener- 
ation branches of two arteries converge, are known 
to be vulnerable to vascular insults such as the 
ischaemic process (245). In the AIB series, substant­
ial changes in cortical permeability occurred in the 
visual area (+84%; a boundary zone of the posterior 
and middle cerebral arteries) and the olfactory area 
(+111%; a boundaiy zone of the anterior and middle 
cerebral arteries). Precisely what factors account 
for the vulnerability of boundary zone regions are 
not known.
Second, neurochemical studies have demonstrated that 
the concentration of histamine elements in the brain 
is non-uniform (85, 219, 220). The anatomical 
distribution of histamine receptors within the micro­
circulation of different brain regions, therefore, 
may be an important factor. A high and heterogeneous 
density of histamine receptors in cerebral cortical 
microvessels, for example, may explain the large and 
variable increase in vascular permeability in this 
region.
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Reversibility
Arterial infusion of histamine produced an increase 
in permeability of the blood-brain barrier that 
persisted for 30 minutes, but, within two hours, 
barrier permeability had recovered to normal. The 
persistence of the permeability increase for at least 
30 minutes after the end of histamine infusion may 
be related to the activated state of enzymes particip­
ating in the response. Studies of nucleotide systems 
in cerebral microvessels (113) have demonstrated that, 
once stimulated, adenylate cyclase activity may be 
sustained for periods up to 30 minutes, even following 
washing and sedimentation. A high energy turnover 
in brain endothelia, reflected by dense mitochondrial 
content (170), significant metabolic activity (36), 
and facility for synthesis of cyclic AMP when stimul­
ated by histamine (12 3, 125), may account for the 
restorative properties of the blood-brain barrier. In 
thalamus, which had normal permeability 30 minutes after 
infusions (Table 3), these mechanisms may be relatively 
more important.
Several other interventions transiently increase 
vascular permeability in brain vessels. Acute 
arterial hypertension, convulsions, arterial hypercapnia, 
and carotid perfusion with lipid-insoluble hypertonic 
solutions are manoeuvers that produce reversible 
increases in barrier permeability lasting from 15 
minutes to several hours (24, 199). Carotid perfusion 
with lipid-soluble hypertonic solutions, such as 
propylene glycol, increases blood-brain barrier 
permeability irreversibly (198). This result may 
be related to destruction of cell membranes in endo­
thelia or to cytotoxic effects on endothelial metabolism 
(198). By contrast, the concentrations of histamine 
used in the present studies were within the physiolog­
ical limit of repair by the blood-brain barrier.
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Receptors
The results demonstrate that receptors were pre­
dominantly responsible for the increase in permeabil­
ity produced by histamine; the receptor blocking 
agent, metiamide, reduced the permeability response 
to histamine, while mepyramine, an receptor antag­
onist, was mostly ineffective. This discussion 
will focus on three points concerning receptors: 
first, evidence for histamine receptors in cerebro­
vascular endothelia; second, the localisation of 
action by metiamide; and third, comparisons with 
other., studies which have examined histamine receptor 
involvement in vascular permeability changes.
Evidence for the„presence of histamine receptors in 
brain microvessels has emerged almost entirely from 
the work of Joo and colleagues (123). Over several 
years of research effort, these investigators have 
identified a histamine-sensitive cyclic nucleotide 
system in brain capillaries, and have proposed that 
histamine and cyclic AMP are important to normal and 
pathological function of the blood-brain barrier (121, 
123). In a recent report, Karnushina et al. (125) 
showed that stimulation of adenylate cyclase by 
histamine was mediated by receptors. receptors
were present but not important to adenylate cyclase 
activity. The presence of histamine-sensitive enzymes 
has been confirmed in other laboratories (8, 113), 
but specific receptors mediating their effects were 
not identified.
Several studies have provided evidence for histamine 
receptors in brain slices or homogenates (85, 220) .
It is not known, however, whether these receptors 
are incorporated in neuronal tissue or within blood 
vessels and endothelia. Three of the brain regions 
studied in the present experiments, diencephalon, 
hippocampus, and cerebral cortex, have relatively
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high concentrations of both and receptors 
(85, 188, 219, 220). A high concentration of hista­
mine elements in certain brain regions may indicate 
that vascular responses are more readily detectable.
It is interesting^ from this line of rationale that 
attenuation of increased permeability in hippocampus 
by mepyramine (Figure 5) may have occurred because 
this brain region is relatively rich in receptors. 
Generally, however, receptors were primarily 
responsible for the increase in brain vascular 
permeability during histamine infusion.
The above conclusion extends from the finding that 
metiamide blocked the histamine effect. Metiamide is 
a water-soluble protonated compound, and has poor 
penetration from blood into the central nervous system 
(13, 171, 211). Nevertheless, in a previous study, 
metiamide was effective in reducing oedema caused by 
exposure to radiation (122). In the present experi­
ments, metiamide was given before histamine infusion, 
and, therefore, would have been deposited at 
receptors before the beginning of histamine stimulation. 
It is worthwhile to consider, therefore, at what site 
in the cerebral circulation metiamide could exert its 
blocking effect on histamine. Two loci, neither 
involving complete penetration of the drug from blood 
to the central nervous system, are possible. First, 
metiamide may occupy receptor binding sites on the 
luminal plasma membrane of endothelial cells. This 
locus has been identified as an important structural 
site for binding by circulating hormones (176).
Second, metiamide may reach significant intraendothelial 
concentrations by simple dissolution and diffusion 
within the aqueous phase of plasma membranes. Within 
the endothelial cytoplasm, metiamide may inhibit 
histamine-sensitive adenylate cyclase and prevent the 
formation of cyclic AMP, which could influence 
vascular permeability mechanisms (123).
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Previous studies in skeletal muscle and skin prepar­
ations have identified the receptors involved in 
vascular responses produced by histamine. Thermal 
injuries in limbs of rats cause systemic levels of 
histamine to increase (111); resulting local 
increases in blood flow and oedema formation are 
mediated by receptors (29). In blood vessels of 
human skin, both and receptors mediate 
erythemic responses to intradermal injection of 
histamine (207). Furthermore, it has been clearly 
shown in cat skeletal muscle studies (71, 72) that 
both classes of receptors mediate increases in 
vascular permeability and oedema formation produced 
by arterial infusion of histamine. In rat brain in my 
studies, mediation of increased permeability to hista­
mine only by receptors may indicate a species 
difference, or may indicate a regional organ difference 
in distribution of histamine and receptors.
These possibilities have been discussed previously by 
several authors (13, 72, 171, 211).
Magnitude
From intra-carotid infusion of histamine, increases in 
cerebrovascular permeability of up to 237% were 
determined from the two quantitative methods applied 
in the present studies (Figures 3 and 6). There are 
no available studies with which to directly compare 
the permeability results with histamine: previous
reports examining the effect of histamine at the 
bloodrbrain barrier have not used quantitative method­
ology (74, 81, 115), and there are no other studies 
in which agents that might influence vascular permeab­
ility in the brain have been administered by intra- 
arterial infusion.
There are, however, several studies that have applied 
quantitative methods to examine blood-brain barrier 
permeability in pathological conditions that could
94
involve histamine release. Among these reports, 
low level irradiation (205) and hypoxic ischaemia (181) 
were associated with alterations in the permeability 
of cerebral microvessels of about the same magnitude 
as the present studies. Both of the experiments, 
however, used quantitative morphological technique 
(counting of endothelial vesicles) which does not 
provide information concerning the rate of solute 
passage into the brain.
Other perturbations that affect blood-brain barrier 
permeability, and have been quantitatively studied, 
include convulsive seizures (142), acute arterial 
hypertension (104), gliosarcoma tumours (139) , and 
carotid perfusion with hypertonic solutions (201).
These conditions are associated with very severe 
disruption of barrier function, with four to 20-fold 
increases in permeability occurring. The increase 
in permeability produced by histamine, therefore, 
represents a change in properties of cerebral endo­
thelia that is considerably more subtle than has 
been previously determined.
It is interesting to compare the results of the pres­
ent studies in brain with those obtained in a peripher­
al organ circulation. In the isolated dog hindlimb, 
intra-arterial infusion of histamine in doses of 1-5 
pg min kg did not significantly increase capillary
filtration coefficients, but at doses of 20 - 60 ug 
“1 -1min kg , similar, therefore, to the present 
experiments, filtration coefficients were increased 
100 - 200% (48). As this measurement in muscle 
primarily reflects the rate of fluid movement across 
microvessels (49), the results of the two studies are 
not directly comparable, but, nevertheless, provide 
an example of similarity in response between two very
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different microvascular beds.
Mechanism.
Increases in permeability of the blood-brain barrier 
to circulating solutes are typically the result of 
widened interendothelial junctions and/or activation 
of pinocytosis and vesicular transport (24). It 
is useful to consider also the possible mechanisms 
ascribed to increased vascular permeability in non- 
neural organs. For these tissues, in addition to 
the above responses, an increase in capillary surface 
area, an increase in the number of pores (open cell 
junctions) per unit surface area, and the formation 
of transcellular channels from chains of vesicles 
are possibilities (27, 204). These items will be 
considered in this section.
The increase in permeability x surface area product 
seen with histamine infusion in several brain regions 
may simply be a reflection of increased tissue per­
fusion, i.e.,increased capillary surface area. Two 
of my findings in separate studies however, do not 
support this argument. First, there was no detect­
able increase in local blood flow to the regions of 
brain in which increases in permeability occurred 
(Table 9), This finding would suggest that 
histamine infusion did not increase the effective 
perfusion area in the vascular bed. Second, hista­
mine infusion tended to decrease, rather than increase, 
regional vascular volume (Table 2). Thus, the area 
within a given unit length of microvessel appeared not 
to be larger. Taken together, these findings suggest 
that histamine did not cause "capillary dilatation", 
a condition that would be associated with increased 
surface area for blood-to-brain solute transport.
Histamine may cause widening of tight junctions at 
apposing brain vascular endothelial cells. Previously, 
the prototype condition for this kind of barrier open­
ing involves adminstration into the carotid artery of
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hypertonic, lipid-insoluble solutions (198, 201).
An osmotic effect on endothelial cells ensues, 
involving loss of cell water to blood and shrinking 
of cellular volume (26, 199). The histamine 
solution in the present studies was not hypertonic, 
and was unlikely to produce an osmotic effect in 
the cerebral vascular bed.
It is possible, however, that histamine stimulates 
contractile mechanisms that are present in brain 
microvessels (134, 174), Contraction of endothelia 
in capillaries or venules could lead to widening of 
interendothelial junctions. This response to 
histamine, associated with reversible deformation of 
endothelial nuclei, has been observed previously in 
blood vessels of skeletal muscle (148) and mesentery 
(79, 124). Whether this response occurs uniformly 
throughout the microvascular bed, to involve an 
increase in the number of open interendothelial 
junctions (pores) per unit surface area, has not been 
examined. In thermal injuries, circulating histamine 
levels are increased (111), and may be a factor in 
the genesis of blood-brain barrier disruption and 
cerebral oedema from widening of interendothelial 
junctions that accompany severe burns (12).
Histamine may stimulate pinocytotic mechanisms and 
vesicular transport. Activation of this response 
could lead to formation of endothelial channels or 
chains of contiguous vesicles (143, 199, 204). 
Previously, Joo and colleagues have proposed that 
histamine stimulates vesicular activity by activation 
of adenylate cyclase in brain endothelia (121, 123). 
From this enzyme system, cyclic AMP, which may 
determine the energy level in .the cell, is synthesised 
(125). Vesicular activity, and contractile processes, 
in brain endothelia, therefore, may be dependent on 
the formation of cyclic AMP. This mechanism has 
been discussed previously for the biogenic amine, sero­
tonin (242) .
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Influences by circulating active agents on the 
permeability of water at cerebral blood vessels 
have not been well defined. Intra-arterial infusion 
of histamine in the present studies produced oedema 
in grey matter, which may reflect a change in water 
permeability. Four processes may be involved to 
explain an increase in brain tissue water content 
during histamine administration. First, histamine 
may directly affect membrane properties for water 
transport in cerebral endothelia. This mechanism 
has been proposed previously for skeletal muscle 
vessels (11) and for sheep lung (25). Second, 
histamine may stimulate elaboration of vasopressin 
which regulates sequestration of water from blood (76, 
135). Vasopressin release is sensitive to histamine 
given systemically (51, 233), but it has not been 
shown that high intra-arterial levels of histamine, 
such as during carotid infusion, cause vasopressin 
release. Possible vascular mechanisms evoked by 
circulating histamine, as related to drinking behaviour 
and water balance, have been discussed by Leibowitz 
(135). Third, an increase in microvascular hydro­
static pressure would increase blood-to-tissue filt­
ration (69, 90). A decrease in the ratio of pre- 
to post-capillary resistance, as is observed in 
skeletal muscle preparations during histamine infusion 
(46, 47, 89), could account for increased water move­
ment by bulk flow from blood into the brain. These 
microcirculatory hemodynamic alterations, however, 
should be reflected by a change in the rate of tissue 
perfusion (11,46). Since an increase in cerebral 
blood flow was not seen during histamine infusion 
when the blood-brain barrier was intact, this 
mechanism, by itself, does not seem likely. Fourth, 
because histamine increases vascular permeability to 
circulating solutes, the osmotic pressure balance 
between plasma and interstitial fluid will favour a 
gradient toward brain. In this case, plasma water 
driven by vascular hydrostatic pressure, and osmotic
solutes entrained in the convective stream, would 
act synergistically to produce a "vasogenic" oedema 
(69) .
Implications
A multiple capacity for forming, storing, and releas­
ing histamine is present in the brain, especially in 
the vicinity of blood vessels (99, 117). In this 
section, I will discuss five circumstances in which 
histamine could have a role in influencing cerebral 
vascular permeability vivo. The first four 
items (Figure 18) relate to sources of histamine 
that may be involved in initiating permeability 
changes. Finally, I will discuss the implications 
of histamine's effect on the permeability of brain 
blood vessels with reference to its participation in 
pathological and immunological responses.
Figure 18 depicts four possible conditions in which 
histamine could initiate changes in vascular permeab­
ility vivo. First, histaminergic neurones are 
present in several brain regions (85, 219, 220). If 
activation of these neuronal path-ways produced 
significant changes in metabolic activity, then 
vascular permeability could be affected by vasoactive 
metabolites. Additionally, central neurones may 
innervate cerebral micro-vessels (56), and influence 
the level of local blood flow and vascular permeabil­
ity (195) . If histaminergic neurones have vascular 
innervation, then permeability of the blood-brain 
barrier may be under this form of neural regulation.
Second, histamine is present in cerebral perivascular 
mast cells (58, 116, 117), and may be released locally 
by adjacent nerve stimulation or by the presence of 
mast-cell releasing factors, such as antigens, kinins, 
and histamine itself (22, 187, 206). There is 
evidence from studies in skin that mast cell degranul­
ation occurs explosively, and that the resulting
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effects on vascular permeability and blood flow are 
reversible with time (6 8 ). Furthermore, it appears 
that mast cell histamine may influence vascular 
responses entirely through the class of histamine 
receptors located on the albuminal side of the vessel 
(30, 190). It is interesting that characteristics of 
the effects of histamine on brain vascular permeability 
as identified in the present studies, viz, reversibil­
ity within two hours, and predominant participation 
by H2 receptors, are similar to those associated with 
mast cell degranulation in other organs.
Third, histamine has been identified within smooth 
muscle layers of brain blood vessels (67) . This store 
of histamine, which may be important to neurovascular 
effects of histaminergic nerves, could serve as an 
instantaneous supply of histamine, participating in 
vascular responses during several conditions. Local 
smooth muscle levels of histamine may be sensitive 
to the metabolic state of the smooth muscle cells.
If the catabolic enzyme for histamine, histamine-N- 
methyltransferase, were inhibited during a metabolic 
disturbance, then local levels of histamine may 
increase sufficiently to influence vascular permeabil­
ity.
Fourth, focal and/or systemic levels of histamine may 
be increased during some pathological conditions.
Migraine headache (5) and peripheral thermal injuries 
(1 1 1 ) are conditions in which increased circulating 
levels of histamine have been measured. Additionally, 
it is known that histamine is released from circulat­
ing basophils during immune and allergic reactions (187). 
Under these conditions, histamine may increase 
vascular permeability by stimulation of endothelial 
membrane receptors. The present experiments indicate 
that this effect would be mediated through H2 receptors.
If histamine were to increase cerebrovascular permeabil­
ity during such conditions as migraine headache, then
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Figure 18. Possible sources of histamine that may 
influence cerebrovascular permeability 
in vivo. See corresponding text for 
comments and references.
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the concentration in brain of other vasoactive, or 
metabolically active, substances may become import­
ant. An hypothesis involving the relevance of 
blood-brain barrier integrity has been proposed by 
Harper and associates (97) to explain the possible 
participation of several agents that might influence 
cerebral vascular or metabolic states during migraine.
The participation of histamine in inflammatory and 
immune reactions has been recognised for many years 
(22, 114, 140, 227, 243, 247). Although histamine 
may be involved as a modulator of cerebral vascular 
permeability in several pathological conditions (e.g., 
anaphylaxis, headache, head injury, ischaemia, tumour 
invasion), I will focus this part of the discussion 
on its role in the inflammatory process (e.g., for 
brain, meningitis, encephalomyelitis). The events 
occurring during inflammation resemble, or may be a 
part of, the sequelae of cerebral vascular responses 
associated with various types of brain pathology.
Inflammatory reactions typically involve histamine 
release from perivascular mast cells and circulating 
basophils (114, 187). The available histamine appears 
to evoke two types of effects that influence vascular 
permeability: "pro-inflammatory" and "anti-inflammat­
ory" actions (187) . Pro-inflammatory actions of 
histamine are principally designed to increase vascular 
permeability to facilitate the migration of complement, 
primarily leukocytes and immunoglobins, from blood to 
the abluminal site of inflammation (22, 186, 187).
The anti-inflammatory action of histamine operates as 
a negative-feedback mechanism, such as by inhibiting 
further histamine release from mast cells and baso­
phils, and by retarding lysosomal enzyme release from 
neutrophils (187) , It is interesting that the two 
classes of histamine receptors can mediate individually 
separate steps in the inflammation process (186, 187).
Brain vascular receptors, although not participating 
directly in permeability responses to circulating
1U2
histamine, may therefore have an important role in 
inflammation regulation.
If histamine were an important mediator of brain 
vascular permeability responses in inflammatory-like 
conditions, then it should be possible to clinically 
treat these diseases with specific histamine-blocking 
agents. For conditions in which anti-histamines 
have been used, such as in migraine headache (161), 
it has been disappointing that the drugs do not 
satisfactorily alleviate symptoms. Possible 
explanations for the failure of histamine antagonists 
in these conditions are: 1 ) mediators other than
histamine, such as serotonin, may be more important 
to the vascular response and symptoms than histamine;
2 ) local levels of histamine may be higher than the 
effective capacity for blockade by the histamine antag­
onists in the doses used; 3) therapeutic blockade 
at only one type of receptor may not be sufficient.
The present experiments show that H 2 receptors 
blockade can prevent permeability increases to arter­
ially infused histamine. Under different conditions, 
however, both receptors may need to be blocked 
simultaneously for effective antagonism (40, 171);
4) the site from which histamine exerts its effect 
may not be readily determined or reached by clinical 
administration. If histamine is released perivascul- 
arly, for example, then pharmacological blockade by 
currently available receptor antagonists may not 
be possible because these agents do not readily pass 
the blood-brain barrier (219).
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Discussion II. Cerebral Blood Flow.
The principal findings in the blood flow studies 
were 1 ) intra-arterial infusion of histamine, when 
the blood-brain barrier was intact, did not affect 
cerebral blood flow. Because arterial pressure 
decreased significantly, the maintenance of cerebral 
blood flow must be ascribed to autoregulatory 
dilatation of brain resistance vessels. Cerebral 
vascular resistance decreased significantly during 
histamine infusion; 2 ) after disruption of the 
blood-brain barrier, infusion of histamine caused 
dose-dependent decreases in cerebral vascular resist­
ance, and increases in blood flow. Measurement of 
local brain blood flow with iodoantipyrine indicated 
that increases in blood flow occurred in several 
regions; 3) the increase in blood flow was mediated 
by both and K2 receptors; and 4) the increase in 
blood flow with histamine was due tp stimulation of 
vascular histamine receptors mediating dilatation, 
rather than a result of stimulation of cerebral metab­
olism which would have produced increases in blood 
flow secondarily.
Relevance of the Blood-Brain Barrier
The importance of the blood-brain barrier to circulat­
ing amines has been recognised for many years (59,
147). In the present studies, no effect of intra- 
arterial histamine on blood flow could be observed 
unless blood-brain barrier mechanisms were first 
disrupted by carotid injection of hypertonic urea.
The failure of histamine to exert an effect on cerebro­
vascular smooth muscle when the blood-brain barrier 
was intact may be ascribed to two reasons. First, 
sufficient concentrations of histamine to produce 
vasomotor responses may not be obtained because 
histamine does not readily pass the morphological 
components of the blood-brain barrier, i.e., either 
through interendothelial junctions or via vesicular
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transport. Second, circulating histamine that 
penetrates to the cytoplasm of brain vascular endo­
thelial cells may be catabolised by degradative 
enzymes. This enzymatic mechanism of the blood- 
brain barrier has been clearly shown for the mono­
amines, dopamine, noradrenaline, and 5-hydroxytrypt- 
amine (16, 174). Monoamine precursors are actively 
transported into microvascular endothelial cells 
where they are decarboxylated to the respective amine, 
then deaminated by monoamine oxidase (174), a process 
which renders the amine inactive. For histamine, 
however, oxidation by monoamine oxidase is not a major 
pathway in the catabolic process (52). Ring méthylation, 
by histamine-N-methyltransferase, and oxidative 
deamination, by diamine oxidase, are the principal 
routes for catabolism (13, 52, 211). Although hista­
mine enzyme systems are present in the brain (85, 220, 
231), it is not known to what extent they are localised 
to the vascular endothelium where they would have an 
important function in forming a blood-brain barrier 
to histamine.
In preliminary studies, I demonstrated that carotid 
injection of hypertonic urea caused a four-fold increase 
in vascular permeability to sucrose (molecular weight - 
342 daltons). In a previous study in rats (92), it 
was shown that carotid injection of urea increased 
the brain uptake of noradrenaline (molecular weight =
16 8 daltons) by approximately four-fold. Thus, 
because histamine dihydrochloride has a similar 
molecular weight (184 daltons) to noradrenaline, 
vascular permeability to histamine in the present 
studies was probably increased by about four-fold. An 
increase in the permeability to histamine at the level 
of arterioles and metarterioles could explain the 
increases in cerebral blood flow during histamine 
infusion. Stimulation of histamine receptors on 
inner layers of vascular smooth muscle would appear 
to be the most likely mechanism for producing
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dilatation. The possibility that histamine passed 
from blood to the outside of cerebral vessels to 
evoke an effect seems unlikely because 1 ) brain 
arterioles appear to have predominantly H 2 receptors 
distributed along outer surfaces (238), and 2) hist­
amine infusion was not associated with detectable 
increases in brain uptake of glucose (see below).
Because both classes of receptors participated in 
dilatatory responses to infused histamine. I speculate 
that and H2 receptors are distributed equally along 
inner layers of smooth muscle in brain arterioles.
Several previous studies in baboons have demonstrated 
the importance of blood-brain barrier mechanisms in 
determining cerebral circulatory responses to arterial 
administration of amines. Noradrenaline, 5-hydroxytrypt- 
amine, and low doses of phenylethylamine are without 
significant effect on cerebral blood flow unless blood- 
brain barrier mechanisms are first disrupted by 
hypertonic solutions of enzymatic inhibitors (98, 145, 
153). From the results of the present studies, histamine 
can be added to this category of putative neurotrans­
mitter substances having cerebral vasomotor effects 
that depend on the integrity of the blood-brain barrier 
(147).
Regionality
The regional pattern of cerebral blood flow responses 
to arterial infusion of histamine may derive from two 
anatomical factors: the distribution of histamine
delivery in blood to the cerebrovascular bed, and the 
distribution of vascular histamine receptors in each 
brain structure.
Infusion of histamine into the internal carotid artery 
in rats provides for delivery of the drug primarily 
to brain regions in the distribution of the middle 
cerebral artery (100, 246). In the present studies,
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hypothalamus, thalamus, caudate nucleus, hippocampus, 
and parietal cortex were the structures in which 
increases in blood flow occurred during histamine 
infusion. Each of these regions is supplied by 
branches of the middle cerebral artery (246). It 
cannot be determined from the present studies whether 
there were differences in magnitude of vascular 
response between white and grey matter structures. In 
regions not supplied by blood from the internal carotid 
and middle cerebral arteries, i.e., brainstem and 
cerebellum, there were no responses to histamine 
infusion. In summary, therefore, these studies 
indicate that histamine increases blood flow in brain 
regions where the blood-brain barrier is disrupted and 
where histamine is infused.
In brain structures where blood flow responses to 
histamine were detectable, there was no particular 
uniformity in the blood flow increase according to 
structure. A difference in regional responsiveness 
may arise from differential localisation of vascular 
receptors for histamine in the brain regions examined. 
For example, for each of the histamine agents infused 
(Tables 10-11 ), parietal cortex showed the greatest 
increase in blood flow. An approximate order of 
responsiveness may be ranked as follows: parietal
cortex > caudate nucleus ^  hippocampus diencephalon. 
During stimulation of receptors by pyridylethyla- 
mine, however, relatively larger increases in blood flow 
to hypothalamus and thalamus occurred (Table 11).
This pattern may suggest a denser population of 
receptors in blood vessels of the diencephalon.
Receptors
Identification of receptors involved in cerebral blood 
flow responses to histamine was approached along two 
methodological lines. In the first series involving 
the xenon clearance method, it was demonstrated that 
histamine could produce increases in blood flow after
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the blood-brain barrier was disrupted with urea.
Blood flow responses to histamine were reduced 
when animals were pretreated with specific blocking 
agents, either the receptor antagonist, mepyramine, 
or the H2 receptor antagonist, metiamide. Both of 
these blocking agents -are known to be specific 
antagonists for their respective receptors (52). In 
the second series of studies using the iodoantipyrine 
tissue sampling method, the results showed that carotid 
infusion of histamine or specific receptor agonists 
after blood-brain barrier disruption increased cerebral 
blood flow. Regional responses to histamine, pyri- 
dylethylamine (H^ receptor agonist) and dimaprit(H2 
receptor agonist) were of approximately the same 
magnitude. Taken together, the results of the above 
two studies indicate that both and H 2 receptors 
are present in cerebral vessels, and that both classes 
of receptors can mediate vascular dilatation.
Several studies have been undertaken to determine 
whether histamine receptors are present in brain 
tissue (85, 219), but it is not clear if the receptors 
are partitioned between neuronal elements and the 
vasculature.. Both receptor types have been identified 
in brain homogenates and slices (2 2 0 ), and, in a 
recent study, it was shown that stimulation at both 
receptors could activate adenylate cyclase (188). 
Formation of cyclic AMP may be important to molecular 
mechanisms that could influence vascular smooth muscle 
(1, 4). Histidine, and the metabolic enzymes for 
histamine, which would be important to the regulation 
of receptor activity vivo, are present in all of 
the brain regions which demonstrated blood flow 
responses to histamine in the present studies (231).
Mechanism
Increases in organ blood flow may result from one or 
both of two possible mechanisms. The metabolic 
demand of the organ may increase, which would produce
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secondarily an increase in organ perfusion, or 
resistance vessels in the organ may dilate under 
extrinsic neural or chemical stimulation (1, 76). 
Previously, for most of the putative neurotransmitt­
ers examined to date, it has been demonstrated that 
increases in cerebral blood flow in response to 
arterial infusion of the agents have been associated 
with concomitant increases in cerebral metabolic rate. 
Noradrenaline (145), dopamine receptor agonists (151, 
155), and vasoactive intestinal peptide (154) can be 
categorised as agents which appear to stimulate 
cerebral metabolism, producing, secondarily, increases 
in cerebral blood flow. Acetylcholine,which is also 
a possible neurotransmitter in the central nervous 
system, increases cerebral blood flow without detect­
able increases in metabolic rate (105); presumably, 
this amine stimulates cholinergic receptors in 
cerebrovascular smooth muscle to produce vascular 
dilatation.
The results of the present studies suggest that 
histamine causes dilation of cerebral vessels without 
influencing metabolic rate in the brain. The increases 
in blood flow probably resulted from direct stimulation 
of vascular histamine and receptors. Infusion 
of histamine into the internal carotid artery after 
blood-brain barrier disruption did not increase brain 
up-take of glucose, as determined by the 2 -deoxyglucose 
method. Infusion of noradrenaline, however, did 
produce increases in glucose utilisation, indicating 
that the method could detect changes in metabolic 
demand if they occurred. The magnitude of change 
in glucose uptake evoked by noradrenaline is similar 
to that determined previously in baboons (145), and 
to the effects on cerebral blood flow in rats after 
blood-brain barrier disruption (60).
In available literature concerning the effect of 
histamine in the cerebral circulation, there is'
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considerable confusion about the effect this amine 
may have on vessels supplying, and within, the 
brain. Several earlier reports indicated that intra- 
arterial infusion of histamine increases cerebral 
blood flow in different species (Table 13). In these 
studies, measurements were obtained 1 ) from extra- 
cranial vessels supplying the brain, and/or 2 ) in 
species such as dogs and cats, animals in which major 
vessels serving the brain are known to. anastamose with 
extracranial tissues (118), Both of these circumstances 
may lead to errors in interpretation. Concerning the 
first point, histamine-induced dilatation of the 
internal carotid artery, for example, would not 
necessarily be associated with dilatation of vessels 
distal to the circle of Willis. This separation 
of vascular responses has been clearly shown for the 
vaso-constrictor substance, 5-hydroxytryptamine (98); 
in baboons, intracarotid infusion of 5-hydroxytrypt- 
amine caused marked constriction of the internal 
carotid artery, but did not reduce cerebral blood flow 
unless the blood-brain barrier was first disrupted. 
Cerebral vascular autoregulatory mechanisms would 
explain this phenomenon. Likewise, a similar series 
of vascular events may apply to histamine: intra­
carotid infusion probably dilates the internal carotid 
artery, but, as shown in the present studies, and in 
those by Eidelman et al. (64), cerebral blood flow 
does not increase. Concerning the second point above, 
species differences in vascular response may account 
for some of the confusion. These differences may involve 
the distribution and density of histamine receptors in 
cerebral vessels, blood-brain barrier permeability, or 
vascular anatomy. In studies using dogs, however, 
there are serious limitations in examining cerebral 
blood flow responses to intra-arterial drug administ­
ration (105).
The molecular mechanisms by which histamine induces 
vascular smooth muscle responses are not yet clear (34),
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In vitro studies in cultured neural cells and nerves 
indicate that stimulation of. H-. receptors is 
associated with facilitated Ca"^  influx, glycogenol- 
ysis, and synthesis of cyclic GMP (219). Stimulation 
of receptors is strongly linked to cyclic AMP (85, 
150, 219). In the rabbit ear artery preparation, 
responses to stimulation of receptors are mediated 
by efflux of K*^  and release of Ca^^ from intra­
cellular stores, while responses to stimulation of
4-
receptors are not dependent on K flux and are
2 +associated with diminished release of Ca from intra­
cellular stores (34) .
Implications
The interactions of histamine with cerebral vascular 
smooth muscle vivo appear to be complex. They 
depend on three types of cellular storage, two 
distinct receptors, the integrity of the blood-brain 
barrier, and the particular brain region stimulated.
Histamine is richly concentrated in mast cells located 
along the adventitial border of brain blood vessels 
(58, 116). Should histamine be released from these 
cells, potent vasoactive effects could ensue. A non­
mast cell pool of histamine is found within cerebro­
vascular smooth muscle (67). No specific function 
has yet been associated with this source of histamine 
but it is possible that nonmast cell histamine 
modifies effects of cerebrovascular nerves. Histamine 
is also found within neural tissue (85, 220). There 
is strorg evidence that this source of histamine partic­
ipates in synaptosomal transmission (85, 220). If 
histaminergic nerves innervate cerebral blood vessels, 
then vasomotor regulation could be influenced by neural 
withdrawal or stimulation, as has been proposed for 
peripheral reflexes (14, 31, 190), and central adren­
ergic neurones (195).
The present studies suggest that histamine may be
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important to cerebral vascular function in patholog­
ical conditions where its release is likely to occur. 
Brain tissue trauma (247) or inflammation (114, 227) 
could involve liberation of histamine. Under these 
circumstances, vascular dilatation may result from 
stimulation of both classes of histamine receptors.
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Discussion III. Pial Vessels in Situ
Two series of studies were performed to characterise 
the responses of pial arterioles and veins to 
stimulation of histamine receptors. In the first 
series, comparisons were made between responses of 
arterioles and veins to application of histamine 
agents. Two important results emerged from these 
studies: 1 ) arterioles responded to injection of
histamine and H 2 receptor agonists, suggesting 
the presence of and H2 receptors in brain resist­
ance vessels, and 2 ) veins were unresponsive to 
histamine agents, in contrast to arterioles which 
showed distinct responses. Part of the discussion 
will focus on factors that could account for these 
results.
In the second series, vasoconstrictor responses to 
noradrenergic stimuli were examined during simultan­
eous application of the histamine agents to determine 
whether significant interaction occurred between 
the putative neurotransmitters, noradrenaline and 
histamine. Stimulation of histamine receptors inter­
fered with noradrenergic effects at pial arterioles 
and veins. The loci of interaction:,, and the 
implications of these results for neural control of 
cerebral vessels, will be discussed in this section.
Eistaminé Agonists
Arterioles. The results demonstrate that histamine,
and each of the histamine receptor agonists, produces
dilatation of pial arterioles when the drug is given
by perivascular microinjection. Histamine produced
increases in arteriolar calibre up to +28% at a
-4concentration of 10 M, results that confirm previous 
findings in another laboratory (238). The new 
information in this study.",' however, was that an order 
of potency for dilatation can be established when the 
three agents for stimulation of histamine receptors 
are considered together: ^ 2  > histamine >  . Thus,
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in contrast to the conclusion of Wahl and Kuschinsky 
(238), the present experiments provide experimental 
evidence for the location of histamine receptors 
on the outside of brain arterioles. Furthermore, 
specific stimulation of receptors produced stronger 
dilatations of pial arterioles than did histamine 
itself.
Because histamine receptors have been previously 
identified in brain tissue preparations (219), it is 
not surprising that receptors may be localised in 
pial arterioles. Both and receptors have been 
functionally identified in most preparations for 
studying cardiovascular responses to histamine (171). 
The conclusion by Wahl and Kuschinsky (238) that only 
receptors mediate histaminergic dilatation of brain 
arterioles was made on the basis of studies using 
histamine receptor blocking agents. In the present 
experiments, specific receptor agonists were used.
The smaller response of pial arterioles to receptor 
stimulation may be related to the density of this 
type of receptor on the outside of the vessel wall.
It is possible that H 2 receptors are more densely 
populated, and receptors more sparsely populated, 
along the outer layers of smooth muscle in brain 
arterioles. A suggestion for this kind of arrange­
ment of histamine receptors in skeletal muscle and 
cutaneous vessels has been made previously (82, 190),
In these studies, histamine produced smaller responses 
to perivascular injection than did the H 2 receptor 
agonist, impromidine. Two factors may account for 
this difference. First, histamine may act prefer­
entially at receptors (30, 54) , which, due to 
their more sparse distribution or lower pptency, 
mediate smaller responses. Second, impromidine has 
very high and specific affinity for H2 receptors (55). 
Previous studies have demonstrated that impromidine 
is substantially more potent than histamine for'
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producing responses in the cardiovascular system 
(172). It is interesting that, at the doses of
impromidine and histamine producing maximal effects
- 6 -4on pial arteriolar diameter (10 M and 10 M,
respectively), there is also near maximal activation 
of adenylate cyclase in preparations of hippocampal 
homogenates or slices and in cortical microvessel 
fractions (101, 125, 234). The potential importance 
of histamine-sensitive nucleotide systems in brain, 
and possibly cerebral vascular regulation, has 
been reviewed recently (2 2 0 ).
Veins. Pial veins were not responsive to 
stimulation of histamine receptors. Over the two 
concentrations studied, each of the histamine agents 
produced very weak dilatations or no response. This 
absence of vascular responsiveness contrasts with the 
results in pial arterioles, which proved to be very 
responsive to stimulation of histamine receptors 
(Figure 11). ’ Cerebral venous responses to histamine
receptor stimulation also differ somewhat from 
responses in peripheral veins. In skeletal muscle 
and skin vein preparations, histamine has been shown 
to be vasoactive, although the nature of vascular 
response has not been consistent, even within the 
same species. In hindlimb preparations in dogs, for 
example, histamine can increase (89, 189) or decrease 
(46, 47) venous resistance. In skin,muscle and 
mesentery, histamine produces contraction of veins 
(79, 124, 221).
Three factors may explain the difference in vascular 
response between cerebral arterioles and veins, and 
between vein responses to histamine in brain and 
peripheral organs. First, the amount of smooth 
muscle available for vasomotor control is clearly 
less in venous segments (2, 76). Thus, if all other 
factors are not important, thickness of the smooth 
muscle wall may be critical to the magnitude of'
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vascular response to histamine. Second, veins may 
lack tone, due to lower luminal pressure which may 
passively render these vessels unresponsive. It is 
also possible that exposure of the pial circulation 
to atmospheric pressure, as in the open skull prepar­
ation, contributes to reduction of wall tone, more 
in veins than in arterioles. In vessel preparations 
in vitro, histamine mediates contraction of cerebral 
vessels with low tone, and relaxation of vessels pre­
contracted with serotonin (57). In vivo, however, 
veins normally have low wall tension (2, 76) which 
may be important to their response to circulating 
and perivascular agents. Third, histamine receptors 
in cerebral veins may be poorly distributed, or absent. 
The capacity for response to agents which stimulate 
histamine receptors may not exist in the cerebral 
venous circulation.
Interaction of Histamine Receptors With Noradrenergic 
Stimuli
These studies indicate that stimulation of histamine 
receptors interferes with the effects of noradrenaline 
in pial arterioles and veins. Histamine and nora­
drenaline mediated opposite effects on pial arteriolar 
calibre; histamine produced dilatation of pial arter­
ioles, and noradrenaline, either from sympathetic 
nerve stimulation or exogenous administration, constrict­
ed vessels. When the stimuli were applied 
simultaneously, histamine inhibited noradrenergic 
constriction of arterioles via both Hj^  and H 2 receptors, 
during sympathetic stimulation, and via only H 2 
receptors during application of noradrenaline.
In veins, stimulation of histamine receptors prevented 
constriction during sympathetic stimulation, but had 
no influence on the venous response to injected nora­
drenaline, This discussion will consider lines of 
evidence from previous studies to suggest loci of 
interaction at the neuroeffector junction, and how
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this mechanism may operate vivo.
Inhibition of arteriolar constriction during sympathetic 
nerve stimulation was produced by simultaneous 
application of either the or the H2 receptor 
agonist. This result could occur from one or both 
of two mechanisms: the contrictor effect of nerve
stimulation, and the dilator effect of histamine 
receptor stimulation, may have been additive, thereby 
cancelling their respective effects on vascular smooth 
muscle; or, histamine receptors on presynaptic nerve 
endings may inhibit the release or enhance the re­
uptake of the transmitter, noradrenaline. Although 
the first possibility cannot be ruled out, there is 
evidence from other studies that histamine can inter­
fere with noradrenergic mechanisms at sympathetic 
nerve endings. In dcgsaphenous vein strips in 
vitro, McGrath and Shepherd (156) demonstrated that 
the amount of radioactive noradrenaline released 
during sympathetic stimulation could be reduced by 
activation of histamine H2 receptors. Enhancement 
of noradrenaline reuptake via histaminergic mechanisms 
could not be demonstrated because cocaine, which 
inhibits noradrenaline uptake, did not alter the 
responses seen with K 2 receptor stimulation alone (156), 
Inhibition by histamine of vasconstrictor effects to 
sympathetic stimulation has also been observed in the 
dog gracilis muscle and hindpaw preparations (191).
In these studies, Powell (191) demonstrated that H 2 
receptors were responsible for interference in nora­
drenergic transmission at pre-junctional sites. Powell 
also showed that vasoconstrictor responses in the 
hindpaw to injected noradrenaline were attenuated by 
histamine, suggesting a postjunctional site of 
inhibition (191).
These conclusions differ from those of Sevan and co­
workers (17) who suggested that histamine potentiated, 
rather than inhibited, sympathetic effects in rabbit
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basilar arteries dm vitro. These investigators 
showed that contractile responses to transmural 
stimulation and serotonin were greater when hista­
mine was added to the bath medium. The histamine 
effect could be blocked by an receptor antagonist 
(17). It is not clear from their studies, however, 
whether the vessels were in a contracted state at 
the time of measurement. It has been shown previously 
that histamine mediates relaxation of cerebral arteries 
that are precontracted, and contraction of vessels that 
are not given tone (57), Thus, the results of Bevan 
et al.(17) may have been influenced by the level of 
tone in their vessels before study. Support for 
this argument is provided by results for veins in the 
present studies. Veins have less wall tension (tone) 
than arterioles (2, 76); application of histamine 
agents simultaneously with noradrenaline in cerebral 
veins did not prevent the noradrenergic constrictor 
effect, Ilndeed, in some vessels, responses to nora­
drenaline were larger during combination with histamine 
or the agonist (Figures 15 and 16) .
Venous constrictor responses to sympathetic stimulation 
were abolished by each of the histamine agents.
Because veins did not respond to injection of histamine 
agonists alone, these results provide further support 
for the presence of inhibitory histaminergic mechanisms, 
involving both receptor types, at sympathetic pre­
synaptic sites.
The involvement of histamine in autonomic nervous 
mechanisms in peripheral vascular beds has been 
illustrated previously by Ryan, Brody and colleagues 
(31, 215), In Figure 19 are presented schematic 
diagrams to summarise the potential relationships 
between histamine receptors and noradrenergic stimuli 
in cerebral vessels.
In Panel A is shown the anatomical arrangement from 
which interaction between histamine and noradrenaline
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Figure 19. Schematic diagrams depicting possible 
mechanisms of interaction between 
histamine and sympathetic nerves on 
cerebral vessels. See text for 
corresponding discussion. 1: sympathetic 
nerve; 2: mast cell; 3: non-mast cell pool 
of histamine; 4: noradrenergic post­
junctional receptor; and 5: histamine 
receptor,
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could occur. A sympathetic nerve ending, peri­
vascular mast cell, nonmast cell histamine within 
vascular smooth muscle (58, 67, 173), and receptor 
sites for noradrenaline (130) and histamine (238; 
Figures 12-14) are present. Panel B demonstrates a 
possible endogenous mechanism which could involve 
liberation of histamine resulting from sympathetic 
nerve stimulation. Histamine is contained in 
sympathetic nerves (61, 214), and may be released 
with noradrenaline during activation of the nerves.
The released noradrenaline may disrupt mast cell 
membranes (206), liberating histamine, and may have a 
role in activating mobilisation of the nonmast cell 
store of histamine from vascular smooth muscle (215). 
Noradrenaline produces constriction of pial arterioles 
by interaction with adrenergic receptors on the outside 
of the vascular wall (130). In Panel C, the available 
histamine interferes with noradrenaline stimulation at 
the adrenergic receptor site. As demonstrated in the 
present studies, and in those by Powell (191), this 
response is mediated by H 2 receptors in arterioles, 
but does not apply to veins. Panel D shows histamine 
interacting with histamine receptors in smooth muscle. 
By itself, this mechanism always produces dilatation 
of pial arterioles (238; Figures 12-14), but no 
response in veins (Figures 15-17). Panel E depicts 
the prejunctional inhibitory mechanism involving 
histamine. Histamine liberated from any of the three 
possible sources by sympathetic nerve stimulation 
interacts at prejunctional sites, probably inhibiting 
the release of transmitter (191). H 2 receptors (156, 
191), and H^ receptors, as shown in the present 
experiments, participate in this mechanism in both 
arterioles and veins.
Implications
Sympathetic nerves and histamine stores are located 
in close proximity to cerebral blood vessels.
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Although sympathetic innervation is dense (17 3), 
the effects of nerve activation under normal conditions 
may not be important (102, 193). It is conceivable 
that histamine release accompanies stimulation of 
sympathetic nerves and modulates the resulting 
influence on vascular tone.
Possible roles for the store of nonmast cell hista­
mine found within the smooth muscle wall have been 
difficult to identify (30). In vascular studies in 
the dog, Powell and Brody (190) provided evidence 
that release of the smooth muscle store of histamine 
involved activation of both and receptors.
Mast cell histamine, however, may interact only with 
receptors (190). These findings, and the results 
of the present studies, provide a speculative basis 
for the concept that nonmast cell histamine interacts 
with prejunctional adrenergic mechanisms in cerebral 
vessels.
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Discussion IV. Hypothesis: Differential Localisation
of Histamine Receptors in Cerebral 
Vessels.
In recent years, there has been a growing interest and 
experimental evidence for specialised localisation of 
receptors within the walls of blood vessels (50, 53, 
126). Identification of receptor sites in blood 
vessels could provide an important basis for clarify­
ing physiological mechanisms and facilitating pharmac­
ological manipulation in the treatment of vascular 
disorders. To date, available reports have addressed 
only the distribution of adrenergic receptors in 
peripheral blood vessels (50, 53, 70). In this 
section, findings from the three series of studies 
will be synthesised to produce a unifying concept for 
the thesis, viz, there is nonuniform spatial distrib­
ution of histamine H^ and H 2 receptors within the 
cerebral vascular wall (Figure 20).
In the studies evaluating the effect of histamine on 
the blood-brain barrier, histamine was infused into 
the internal carotid artery of rats, and vascular 
permeability was determined using radioactive sucrose 
and an arterial integral method. Histamine increased 
permeability of the blood-brain barrier in several 
brain regions. By use of histamine receptor blocking 
agents, it was demonstrated that the effect of 
histamine was mediated through H2 receptors, located 
probably within the vascular endothelium. An 
receptor blocking agent did not significantly affect 
the permeability response to histamine. The studies 
demonstrate, therefore, that intravascular histamine 
can increase the permeability of cerebral vessels by 
stimulation of H 2 receptors in endothelial cells.
This conclusion is supported by recent heurochemical 
studies which demonstrated that H2 receptors primarily 
mediate the activation by histamine of adenylate 
cyclase in cerebral capillaries (125), H 2 receptors.
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therefore, may be predominantly localised in cerebral 
endothelia (Figure 20).
Two lines of evidence from the present studies 
indicate that and receptors are distributed 
equally within layers of cerebral vascular smooth 
muscle closest to the lumen (Figure 20). Following 
blood-brain barrier opening, histamine infusion into 
the internal carotid artery of rats produced increases 
in blood flow that could be attenuated by either an 
receptor antagonist or an H 2 receptor antagonist. 
Also, following blood-brain barrier opening, infusion 
into the internal carotid artery of histamine or 
H2 receptor agonists produced increases in cerebral 
blood flow that were of similar magnitude. The 
results suggest that increases in brain blood flow 
produced by circulating histamine could be mediated 
by stimulation of both and K2 receptors. The 
response was unrelated to cerebral metabolism, 
suggesting that the effect of histamine involved 
stimulation of vascular receptors. Both classes of 
receptors mediate vascular responses to intra-arterial 
histamine in peripheral organs (30, 171).
A greater sensitivity for dilatation to histamine on 
the outside of blood vessels is mediated primarily 
through H2 receptors. In cat pial arterioles (238), 
and in rabbit ear arteries (82), perivascular stimul­
ation of histamine H 2 receptors produces greater 
responses than stimulation from the luminal side of 
the vessel (82). These findings were confirmed in 
the present studies by use of specific histamine 
receptor agonists which were applied perivascularly 
to pial arterioles in cats. Stimulation of H2 rec­
eptors produced larger dilatatory responses than did 
stimulation of receptors. The results suggest 
that K2 receptors are preferentially localised in the 
outer layers of cerebral vascular smooth muscle (Figure 
20) .
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In summary, the studies suggest the following 
profile of histamine receptor distribution in cerebral 
vessels: 1 ) endothelia: predominantly receptors;
2 ) "inner" smooth muscle: both and H 2 receptors;
and 3) "outer" smooth muscle: predominantly H 2
receptors (Figure 20).
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Figure 20, Differential localisation of histamine 
receptors within the cerebral vessel 
wall.
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Conclusions
Infusion of histamine into the internal carotid 
artery in rats increased the permeability of brain 
blood vessels to circulating solutes. Characterist­
ics of the permeability increase were: 1) the
response occurred in several brain structures, and 
in several areas of cerebral cortex; 2) the response 
was mediated through histamine H 2 receptors; 3) the 
response was reversible within two hours; and 4) 
cerebral oedema accompanied the increase in solute 
permeability.
When the blood-brain barrier was intact, infusion of 
histamine into the internal carotid artery in rats 
did not affect cerebral blood flow. When the blood- 
brain barrier was open, histamine produced concentrat­
ion-dependent increases in cerebral blood flow. Blood 
flow responses to histamine were mediated through both 
classes of histamine receptors (H^ and H 2 ). Increases 
in blood flow were the result of direct stimulation of 
vascular histamine receptors, and were not due to 
stimulation of cerebral metabolism.
Perivascular injection of specific histamine receptor 
agonists in pial arterioles of cats revealed the 
presence of both and H 2 receptors. Stimulation of
H2 receptors produced more potent responses than 
stimulation of receptors. Pial veins did not 
respond to the histamine agents.
Stimulation of histamine receptors interfered with 
noradrenergic constriction of pial arterioles and 
veins. Constriction of arterioles and veins during 
sympathetic nerve stimulation was prevented by 
simultaneous stimulation of or H2 receptor?. 
Arteriolar constriction to exogenous noradrenaline 
was prevented by H 2 receptors, but not by receptors. 
Neither class of histamine receptor affected veno- 
constrictor responses to exogenous noradrenaline'.
127
The studies indicate several loci at which histamine 
receptors can mediate or modify vascular responses 
in the brain. In cerebral endothelial cells, H2 
receptors are important; in smooth muscle, both 
receptor types mediate dilatation, but vascular 
responses may depend on the direction (intravascular 
or perivascular) from which the histamine stimulus 
arises; finally, both receptor types can modify 
adrenergic neurovascular mechanisms.
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